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Preface
This cumulative thesis describes how cell metabolism is influenced by the cells’
reception of extracellular signals and how the diverse subsystems of this response
can be modelled with mathematical approaches of Systems Biology. It is divided
into four major parts, which describe the modelling of cell signalling pathways
(Chapter 2.1), the modelling of cell metabolism (Chapter 2.2), a modelling approach
for the analysis of metabolic reprogramming in a human cancer cell (Chapter 2.3),
and the development of a standardised table format for Systems Biology and cor-
responding webservices (Chapter 2.4).
The first part, ”Signalling pathways: From signal to transcription”, describes ap-
proaches for modelling the transduction of extracellular signals in yeast cells and
how these signals affect gene regulation. It comprises twopublications: (i) ”Network
reconstruction and validation of the Snf1/AMPK pathway in baker’s yeast based
on a comprehensive literature review” was published in NPJ Systems Biology and
Applications and my contribution was taking part in the extensive literature re-
search, filling and maintaining the knowledge database, creating a Snf1 network
reconstruction, generating a Boolean model of the network, and contributing to
the writing of the manuscript. (ii) ”Glucose de-repression by yeast AMP-activated
protein kinase SNF1 is controlled via at least two independent steps” was pub-
lished in FEBS Journal and my contribution was the generation of 24 different hy-
potheses models and a subsequent model discrimination process on the grounds
of experimental data. I also worked on the manuscript.
The second part, ”Enzymatic regulation of metabolic function”, deals with the
obstacles of and requirements for metabolic modelling. Furthermore, it proposes
techniques for analysing the enzymatic regulation of metabolic models. This part
comprises two publications: (i) ”New types of experimental data shape the use
of enzyme kinetics for dynamic network modeling” was published in FEBS Jour-
nal. For this review, my contribution was the conceptual design of presenting the
development of enzyme kinetics and rate laws within the past 100 years. This de-
scription is followed by a state-of-the-art analysis of new experimental data and
their influence on the usage of kinetic modelling today. Here, I wrote large parts of
the manuscript. (ii) The second manuscript has been published in PLOS ONE with
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the title ”Systematic construction of kinetic models from genome-scale metabo-
lic networks”. My contribution to this work was taking part in the collaborative
development of the workflow for large-scale metabolic modelling and providing
the metabolic model with thermodynamically consistent parameter sets and con-
venience rate laws. I also contributed to the writing of the manuscript.
The third part, ”Signals, genes, and metabolism: Towards a holistic view”, intro-
duces my work on cancer cell metabolism. It deals with metabolic reprogramming
via oncogenes and is preliminarily titled ”Carbon tracking in colorectal cancer
cells reveals novel influences of the KRAS and BRAF oncogenes on metabolic re-
programming”. My contributionwas the creation ofmetabolicmodels and the exe-
cution of non-stationary metabolic flux analyses on them. I have also performed a
goodness of fit approach to test the accuracy of the analyses and augmented the
findings by consulting further experimental data. Finally, I wrote the preliminary
manuscript on the project status.
The fourth and final part, ”SBtab: An SBML-interconvertible table format for
data exchange in Systems Biology”, is a technical description of a standardised
table format I helped to develop over the past years. This manuscript has been
submitted to Bioinformatics Journal and is currently under revision. My contribu-
tion to this project was the joint development of the format, the implementation
of software tools, the implementation of the corresponding web interface, and the
writing of the manuscript.
The concluding words put the presented techniques and results into context of
the state of the art and analyse their impact on our understanding of the biological
systems.
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From signal to metabolism:
A journey through the regulatory layers of the cell
Abstract
Cellular life is governed on different layers of regulation, which are tightly in-
terconnected: (i) Signalling pathways transmit extracellular signals to the cells’
nucleus, where (ii) gene regulation translates these signals into proteins, and (iii)
proteins control metabolic functions, which convert nutrients to energy and cell
building blocks. Due to the complexity of each of these systems, they are often
analysed individually or only partially.
Systems Biology is an interdisciplinary field of research that offers techniques
to harvest the information of todays high-throughput experiments. These tech-
niques can be powerful approaches to investigate the aforementioned regulatory
layers of a cell either individually or as awhole. In this thesis, I am employingmeans
of Systems Biology to explore signalling pathways and metabolism, and I provide
novel workflows for modelling and exploring these systems. Both workflows are
focussed on accurate large-scale network reconstructions of the target system.
Since one of the major problems in Systems Biology is the availability of experi-
mental data, the workflows put emphasis on the handling of knowledge gaps. They
are applied on the Snf1 pathway and metabolism in yeast and provide new findings
about this model organism. Furthermore, this thesis presents an in-depth analysis
of metabolic reprogramming in colorectal cancer cells, which yields previously un-
known coherences of metabolic function and oncogenes. Finally, I am presenting a
proposal for a standardised data format in Systems Biology, which is based on data
tables.
In summary, this thesis comprises works on signalling pathways and cell me-
tabolism, which includes novel modelling workflows and new biological findings,
analyses their impact on the scientific state of the art, and proposes directions for
new experimental targets.
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Zusammenfassung
Das Leben undÜberleben einer Zelle wird auf verschiedenen Ebenen streng reg-
uliert. Diese Ebenen sind engmiteinander verknüpft: (i) Signalwege leiten extrazel-
luläre Signale in den Zellkern, wo (ii) die Genregulation diese Signale zu Proteinen
übersetzt, und (iii) Proteine kontrollieren metabolische Funktionen, die Nährstoffe
zu Energie und zellulären Bausteinen konvertieren. Diese Systeme sind hochkom-
plex, so dass sie oft nur einzeln oder nur einzelne Teile davon betrachtet werden.
Systembiologie ist ein interdisziplinäres Forschungsgebiet, das Methoden anbi-
etet, umdie Informationen aus denheutigenHochdurchsatz-Experimenttechnolo-
gien zu extrahieren. Diese Methoden können sehr effektiv sein, um die vorge-
nannten Systeme einzeln oder im Ganzen zu untersuchen. In dieser Doktorarbeit
wende ich Methoden der Systembiologie an, um Signalwege und Zellmetabolismus
zu erforschen, und ich präsentiere neue Arbeitsabläufe für das Modellieren und
Analysieren dieser Systeme. BeideMethoden sind auf großskalige Netzwerkrekon-
struktionen fokussiert. Da die Erhältlichkeit von experimentellen Daten eines der
größten Probleme der Systembiologie darstellt, befassen sich die Methoden ex-
plizit mit dem Umgang mit Wissenslücken. Sie werden auf den Snf1 Signalweg und
den Metabolismus von Hefezellen angewendet und vermitteln neue Erkenntnisse
über diesen Modellorganismus. Des Weiteren präsentiert diese Arbeit eine einge-
hende Analyse vom metabolischen Reprogrammieren in Darmkrebszellen, welche
bisher unbekannte Zusammenhänge von metabolischer Funktionalität und Onko-
genen beinhaltet. Zum Abschluss stelle ich unseren Vorschlag für ein standard-
isiertes Datenaustauschformat vor, welches seinen Schwerpunkt auf Datentabellen
der Systembiologie legt.
Zusammenfassend behandelt diese Doktorarbeit die Signalwege und den Me-
tabolismus von Zellen, inklusive neuer Modellierabläufe und biologischer Erkennt-
nisse. Diese Erkenntnissewerden in denKontext unseres aktuellenWissensstandes
gesetzt und darauf aufbauend werden neue potentielle Ansatzpunkte für Experi-
mente vorgeschlagen.
iv
Contents
1 Introduction 2
1.1 The regulation of cellular life . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Systems Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Structure and Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2 Methods & Results 11
2.1 Signalling pathways:
From signal to transcription . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 Enzymatic regulation of
metabolic function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3 Signals, genes, and metabolism:
Towards a holistic view . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.4 SBtab: An SBML-interconvertible
table format for data exchange
in Systems Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3 Conclusion 38
References 54
4 Appendix 55
4.1 SBtab specification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
v
Listing of figures
1.1 The cycle of Systems Biology . . . . . . . . . . . . . . . . . . . . . . . . 5
1.2 Qualitative versus quantitative modelling . . . . . . . . . . . . . . . . . 7
2.1 SBtab example files . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.2 The interfaces of SBtab . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.1 Regulatory layers of the cell . . . . . . . . . . . . . . . . . . . . . . . . . 39
vi
Acknowledgements
I want to thank my supervisor Edda Klipp for her support and guidance. She did
not only supportme on a professional, but also on a personal levelwith her constant
advise whenever it was required. She introduced me to researchers around the
world and enabled me to develop independence in my research projects.
Next, I am very grateful to my inofficial mentors Wolfram Liebermeister and
Marcus Krantz, who did not only improve my scientific advances significantly, but
also taught me much about the secret politics of science and how to cope with
repeated setbacks and obstacles.
As I am a person craving for harmony, I would not have been able to come this far
without having my best friends also as colleagues. I consider myself a lucky person
to have had the opportunity working besides Katharina Albers, Marvin Schulz,
Jannis Uhlendorf, andMax Flöttmann. You guys are great people and I am grateful
for knowing you. Not to mention that you also qualified as splendid proofreaders
of this thesis. If I were a cell, you guys would be my favourite nutrition, glucose.
But of course, also the rest of the group of Theoretical Biophysics was a great
support. I could work in an overwhelmingly friendly environment and was always
able to find help in need. I want to highlight Jens Hahn for sitting down under the
Christmas tree to proofread this thesis.
This listwould not be completewithout emphasisingmy family: My lovingmother
Michaela, my late father Rainer, my dear brother George, and my late sister Karen
for making me who I am today. Last and with most passion I thank my loving wife
Anne for her patience, her work, and her commitment. She deserves utmost grati-
tude for helping me with the figures of this thesis and the hurdles of this life. Work
can be much easier with a person like her, always standing behind me, cuddled in a
blanket, sipping a cup of tea, and patiently listening to my endless contemplations
on the regulatory subsystems of the cell.
vii
This thesis is dedicated to my little daughter Ella. She only knows about ten
words so far, but often these are the exact words that I long to hear after a long
day at work.
1
1
Introduction
1.1 The regulation of cellular life
Cells are the building blocks of all known life forms and understanding them is
an important prerequisite to understand life itself. Some organisms only consist
of a single cell, while others are vast conglomerates of different cell types form-
ing various cell tissues; a human being, for instance, comprises approximately 1014
cells 1. But although single cells are differing largely from each other, they are not
as diverse as it might seem on first glance. Many cellular key features are highly
conserved throughout different cell types and organisms. This allows us to con-
duct experiments on smaller cells - which are easier to culture and more simple in
structure - and carefully transfer the results for a better understanding of complex
human cellular systems2: Small organisms like the bacterium Escherichia coli, the
fruit fly Drosophila melanogaster, the baker’s yeast Saccharomyces cerevisiae, and
many others have become model organisms due to their short generation times,
the easy accessibility and manipulation of their genetic information, and other
favourable cultivation features3. This makes them ideal living tools to explore cel-
lular life4.
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A cell can be considered one large functional system that consists of many di-
verse regulatory subsystems. Three of the most important cellular subsystems are
the following:
Cell signalling Cells need to be able to react to intracellular and extracellular sig-
nals in order to survive changing environmental conditions. Here, the term
’signals’ is multifarious: It can describe extracellular salt concentrations, nu-
tritient availability, ultraviolet radiation, pheromone concentrations, or pH
value of the surroundingmedium, but also intracellular signals like the output
of DNA damage checkpoints during cell cycle. These signals are transmitted
via intracellular signalling cascades that commonly target the cells’ nucleus.
Within the nucleus, the expression of target genes can be either inhibited or
stimulated, which enables the cell to react to the source signal by adapting
its protein composition5,6.
Metabolism Cell metabolism transforms nutrition to energy and cellular building
blocks. In a series of enzymatically catalysed reactions, carbon sources are
broken into pieces (catabolism). On the one hand, these processes can be
used to produce energy which is required for cellular activities. On the other
hand, the broken down pieces of the nutritional source are used to build up
new cellular components like lipids, nucleotides, or amino acids (anabolism).
The provision of these components by metabolism drives the growth of the
cell. It depends on the current status of the cell, whether catabolic or an-
abolic processes are preferred. This status is determined by intracellular and
extracellular signals7,8.
Genetic regulation The adaptation of a cell to environmental signals ismostly car-
ried out by alterations in gene expression. An ample amount of transcription
factors administers gene regulation, either inhibiting or stimulating gene ex-
pression in dependence of the cells’ prevailing needs. The genetic informa-
tion is transcribed to mRNA, which then is translated into proteins. Proteins
operate all crucial cellular processes and thus execute the cellular response
to signals9,10.
These subsystems are only some of the many layers of cell regulation. They are
complemented by complex mechanisms for cell cycle, transport mechanisms, vol-
ume regulation, cytoskeleton maintenance, and other pivotal processes. The anal-
ysis of these single modules in an either experimental or computational manner
is a tedious task: Not only are they complex in themselves, they also are intercon-
nected onmany levels. The question arises what means are adequate to investigate
the complex nature of these processes 11,12.
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1.2 Systems Biology
The aforementioned biological systems and subsystems can be analysed with
the approaches of a rather new field of research - Systems Biology. The birth of
this field originates in the explosion of scientific knowledge acquisition and the
development of new experimental techniques throughout the 20th century. This
began with the first formulations of more sophisticated enzyme kinetics 13, peaked
over milestones such as the construction of the Rutherford-Bohr atomic model 14,
the discovery of the DNA double helix 15, the cloning of complex organisms like
sheep 16, and ended on nothing less than the sequencing of the human genome 17.
The beginning of the 21st century then rather seemed to accelerate the speed of
scientific evolution than to slow it down: With the dawning of the age of the in-
ternet, vast online databases 18,19,20 were filled with large amounts of experimental
data processed by new high throughput experiments, and international collabora-
tions among scientists were made possible by a few clicks of a mouse. But it was
difficult to reasonably utilise these vast amounts of data and harvest the inherent
information. These circumstances called for the rise of a new research field that
could keep up with the dwindling speed of biological sciences. Its name is Systems
Biology.
Systems Biology is an interdisciplinary field of research that combines methods
and knowledge from computer science, mathematics, physics, chemistry, and bi-
ology. By shifting the focus from the previous reductionist view to a wider angle,
Systems Biology is a holistic approach that tries to understand the ’big picture’ of
a system. A cell can be considered to be such a system and its overall behaviour
is a property that emerges from the interplay of its subsystems: The system we
want to explore is much larger than only the sum of its parts. Its subsystems are all
interconnected, but not neccessarily only in an unidirectional way. For instance,
on the one hand, genes are the origin of a complete organism9, but, on the other
hand, gene products (proteins) can in turn affect gene expression. Already in the
1960s, scientists practised this holistic approach21, but it has become more and
more popular and feasible with the increase of available techniques and data22.
The ever-growing amounts of experimental data retrieved by microarrays, mass
spectrometry, new generation sequencing, or similarly powerful approaches need
to be incorporated into mathematical models to make us able to understand them.
Systems Biology encompasses these advances, thus becoming the field of research
that is required to tackle today’s challenges in biological systems. In summary,
Systems Biology offers new approaches to address the following problems:
• Terabytes of deep sequencing or ”omics” datamake the requirement for com-
putational analyses apparent. Advances in data storage and data analysis are
already obtained.
• The more complex contemporary biology becomes, the more it renders the
intuitive understanding of biological systems infeasible.
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• Bridges between different research disciplines need to be built to exploit
their potentials wherever needed.
• Computational power is still increasing quickly and can be used for analyses
tools, if these know how to exploit it reasonably.
Systems Biology has the theoretical potential to tackle these problems22, which
makes it reasonable to have a more detailled look at how it works in practise.
The iterative cycle of Systems Biology Ideally, Systems Biology underlies an it-
erative cycle of building/refining abstract models of biological target systems and
iteratively conducting new experiments (see Figure 1.1). In the beginning, there is
a hypothesis (or a question) about an existing biological system. To test this hy-
pothesis, a model is built by employing the available data and knowledge about
the system. The model construction is followed by computational simulations and
analyses. The results of the latter can now initiate new iterative cycles for the suc-
cessive improvement of the model by the proposal of new experiments and using
the outcome as newmodel input. Thus, knowledge gaps can be identified and filled.
Finally, the initial hypothesis should be verified or falsified. This proposed cycle is
a generalisation of an idealised workflow in Systems Biology23,24. A closer look
shows that, in practise, there are many more detailled and exhaustive workflows
or pipelines formodel creation, data incorporation, experimental or computational
data generation, model analyses, and combinations thereof25,26,27.
Figure 1.1: The cycle of Systems Biology. The cycle starts with a hypothesis about a biologicalsystem. By integrating the available knowledge and data, a mathematical model is created asan abstract representation of the system. It is used to perform computational simulations andanalyses. Optimisations strive towards amore realistic system behaviour. These outputs areemployed to conduct new experiments. With new data themodel can be refined and anothercycle starts. Ideally, the initial hypothesis is verified or falsified.
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Mathematical modelling approaches A model of Systems Biology is supposed to
describe the biological phenomena of a studied system by deploying mathematical
formulae and techniques. In a best case scenario, a model reflects the behaviour
of the corresponding system perfectly, but in practise this is highly unrealistic.
Mathematical models are always an abstraction of reality. The role of mathematics
in sciences has been elucidated by Box et al. in 1976: The employment of mathe-
matics to subjects such as physics or statistics implies simplifying assumptions of
which we know that they are wrong. The physicist knows that particles have mass,
but still certain approximations rely on the assumption that they do not. Similarly,
the statistician knows that normal distributions are extremely rare in nature, but
still he often uses it for his analyses. Thus, we cannot expect a mathematical model
that describes a biological system to be right, but we can say that it is fit to make
proper predictions under certain conditions. Essentially, all models are wrong, but
some are useful28.
These observations make it even more important to thoroughly choose a mode-
lling formalism that is suited for best describing the target system. Several criteria
and questions come into play when amodeller chooses the formalism: (i) what kind
of question is the model supposed to answer, (ii) how much experimental data is
available for the description of its behaviour, (iii) should it be a small model with
high detail or a coarse-grained model, and (iv) how good is the system explored
so far (availability of knowledge)? Ideally, a model should represent the current
knowledge about a system in an abstract and usable format22. The most common
choices of model formalisms, which all have their advantages and disadvantages,
are:
Boolean models Booleanmodels are a coarse-grainedmodel formalism often used
for large networks. The nodes of the network are switched either on or off,
meaning activity or inactivity of the represented entities. They are connected
by edges, which stand for the interaction behaviour of the connected nodes.
Upon simulation, the node status are updated via the edges by Boolean up-
date rules over discrete time steps. This formalism is conveniently used for
gene regulatory networks or signalling networks (see Chapter 2.1) and does
not need exhausting amounts of parameters. In general, Boolean models
have a very crude time concept that is reduced to equitemporal simulation
steps29. But they can be extended to include uncertainties about the node
states, which makes them probabilistic Boolean models30.
Ordinary differential equations (ODEs) ODE models represent each system ob-
servable with an ordinary differential equation. These allow a dynamic con-
tinuous simulation of a system, which results in the concentration changes
of the observables over time. For this, they have to make several assump-
tions, like large and well-mixed molecule numbers and the choice of kinetic
rate laws for the reactions. The required parameters can be estimated by
the usage of experimental data and a plentitude of available software tools.
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Figure 1.2: Mathematical modelling: quality versus quantity. Quantitativemodels show a highlevel of detail and allow for dynamic simulations and quantitative predictions. Their disadvantageis the high requirement of parameters that limits the possible model size. In comparison, qualita-tivemodels are large in size, but do not offer dynamic detail. In between are stoichiometric andconstraint-based formalisms that aim a compromise between quality and quantity.
However, this prerequisite makes the usage of ODEs complicated for large
systems. In regard of the systems’ scope, ODEs can be applied to various
kinds of biological target systems, e.g. signalling cascades (see Chapter 2.1.2),
metabolic networks (see Chapter 2.2.2), or gene regulatory models31,32.
Stochastic models Stochastic models are a counterpart to deterministic models
like ODE models. The dynamics of the system are considered to be stochas-
tic, which implies that the consideration of statistical physics needs to be
employed for the analysis of such a model. This method can be applied e.g.
for a system that involves few molecules of different substances and the in-
dividual molecules need to be traced. For further details about stochastic
modelling the reader is referred to Wilkinson et al.33.
Stoichiometric models For large metabolic models it can be useful to determine
the flux distribution by analysis methods like flux balance analysis (FBA) or
metabolic flux analysis (MFA). These approaches only require the stoichio-
metric information of a model and are not hampered by the need of kinetic
parametrisation. Both applications can be improved by making them under-
lie individual constraints and both are available for steady state and dynamic
(transient) analyses of the system (see Chapter 2.3)34,35.
There are more modelling formalisms and also hybrids of multiple formalisms.
An overview of the formalisms with respect to their detail and size is shown in
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Figure 1.2. An extensive summary can be found in Machado et al.36. In this thesis,
I have employed ODE models, Boolean models, and stoichiometric models.
The exchange and reproducibility of data andmodels in Systems Biology Math-
ematical models and experimental data should be formulated and stored in a re-
producible manner. As aforementioned, Systems Biology aims at interconnecting
the subsystems of a larger system to achieve a holistic view on it. But this aim re-
quires the possibility to connect models with each other, incorporate experimental
data into automated workflows and softwares, or visualise their content in an in-
tuitive way. These are difficult tasks, since modelling formalisms and formats can
be heterogenous; experimental data sheets are often layouted incidental or ini-
tially unintuitive; network visualisations tend to be unclear at first sight. All these
problems can be tackled by the usage of standard data formats37.
Standard formats are sets of guidelines and conventions for the representation
of different kinds of information. Mathematical models can be stored in the wide-
spread Systems Biology Markup Language (SBML (38)) or MATLAB39. The Inves-
tigation/Study/Assay format (ISA-TAB) provides a spreadsheet format for the ex-
change of experimental data and experiment descriptions40. The Systems Biol-
ogy Graphical Notation (SBGN41) offers three different languages for standardised
graphical representations of biological networks. In interdisciplinary fields such
as Systems Biology, there is a high demand for such exchange formats to facili-
tate the collaboration between experimentalists and modellers. They do not only
enable an unproblematic data exchange, they also allow for the usage of diverse
software tools (e.g. COPASI42 or MATLAB for SBML models): If data adhere to
standard formats, this facilitates automatic processing by software, which makes
research results reproducible. Standards are also important in workflows: Stan-
dardised models and data can be easily routed through the various creation and
analyses steps of exhaustive pipelines. Thus, standards ensure a high reusability of
data, which prevents experiment repetitions or loss of information. This plethora
of advantages advocates strongly for the usage of standard formats43,37.
1.3 Structure and Outline
In my thesis, I am focussing on the adaptation of cell metabolism in response
to extracellular signals. Firstly, these adaptations are crucial, since they ensure
cell survival in changing environmental conditions. Secondly, understanding how
cells respond to signals means a first step to finding drug targets for the treat-
ment of diseases. But following the route of a signal from the extracellular space to
actual changes in metabolic function requires the traversal of heterogenous regu-
lation systems: A signal is received by a cellular receptor, transmitted via complex
signalling cascades, and yields changes in gene expression. The resulting change
in the protein composition of the cell is directly affecting enzyme levels and thus
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the regulation of metabolic function. During this journey from signal to metabo-
lism, several questions need to be addressed. What are appropriate modelling ap-
proaches for the very diverse systems? Are workflows for model generation at
hand or do they have to be invented? What kind of experimental data is available
and howcan it be incorporated? Howcanwe reasonably deal with knowledge gaps?
And finally, - equipped with experimental data and Systems Biology modelling ap-
proaches - what can I contribute to our understanding of metabolic adaptations to
diverse signals and how can this improve the treatment of diseases?
Chapter 2.1 commences the initially announced route by focussing on the way
from an extracellular signal over a signalling cascade to gene regulation. To tra-
verse this first part of the overall route towards metabolism, modelling means
for signalling pathways have to be employed. The question, how a signal can be
transmitted to yield changes in gene regulation, needs to be addressed. For this
purpose, I am introducing a novel workflow for the creation of signalling pathway
reconstructions and their validation with Boolean modelling. This workflow is ex-
emplified on the Snf1 pathway in yeast. Snf1 is the yeast homologue of mammalian
AMPK and the pathway is responsible for glucose derepression of genes involved in
the metabolism of alternative carbon sources. Next, I specifically address the main
knowledge gap of this pathway, the activationmechanism of Snf1, with amodel dis-
crimination process based on experimental data. During these works on the Snf1
pathway, I built models of varying formalisms, identified knowledge gaps of the
pathway, proposed solutions for the gaps, analysed the effect of the pathway on
gene regulation, and introduced a general workflow for generating and validating
signalling pathway reconstructions.
The subsequent chapter 2.2 continues the journey fromwhere the previous chap-
ter left off: After an extracellular signal has induced changes in gene regulation, the
protein composition of the cell is changed. This chapter deals with the effect that
changes in enzyme concentrations have on the regulation of metabolic function-
ality. Firstly, and as a technical prerequisite, I present an extensive analysis of the
evolution of enzyme kinetics and rate laws; these are mathematical formulations
describing reaction dynamics. This preparatory excursion is followed by a pro-
posed workflow for creating large-scale kinetic models of metabolism, which ap-
plies the previously reviewed aspects of enzyme regulation in practise. The work-
flow focusses on the dynamics and stability of kinetic metabolic models, which is
strongly dependent on the parametrisation and enzymatic regulation. It is exem-
plified on a reconstruction of yeast metabolism and offers an intensive analysis on
the regulatory principles of metabolic models.
After the previous chapters have completed the route from signal to metabolism
piece by piece, chapter 2.3 describes a more holistic view on this route. I am con-
ducting a metabolic flux analysis of colorectal cancer cells, which is based on 13C
labelled isotope data and includes the experimental introduction of two mutated
oncogenes. The analysis is extended by consulting proteomic and phosphopro-
teomic data acquired simultaneously from the same cell lines. This approach offers
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a view on the regulatory subsystems of the cell in parallel and allows the drawing
of conclusions about regulatory coherences.
Chapter 2.4 is our proposal to a new standardised data exchange format - SBtab.
It is based on common spreadsheet files and can thus be easily employed by scien-
tists irregardless their technical prerequisites. Moreover, I have developed several
tools for validating SBtab files and converting them to SBML. Besides some es-
tablished standard formats of Systems Biology I have also used SBtab as exchange
format in several workflows of my projects.
Finally, I am closing this thesis with concluding words about the possible impact
of the proposed workflows and the introduced new biological findings.
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2
Methods & Results
2.1 Signalling pathways:
From signal to transcription
2.1.1 Reconstructing signalling pathways
A cell needs to be able to react to signals from its environment to ensure cell sur-
vival. Signals include nutrient availability, pheromone signals, salt concentrations,
UV radiation, and many more. The transmission of such a signal is put into effect
by a chain of intracellular reactions, which is called a signalling pathway. Different
signals are often transmitted by different signalling pathways, but many of them
are interconnected. The pathways yield changes in gene regulation, which repre-
sents how the cell reacts to the signal. This chapter focuses on the question, how
signalling pathways can be modelled and what obstacles have to be faced in the
process.
We propose a novel workflow for the generation of large-scale signalling net-
work reconstructions. The reconstruction can be exported as a Boolean model,
which enables a validation process for the network: A set of input nodes (represent-
ing stress signals) can be switched on or off, the model is then simulated, and the
set of output nodes (gene regulation targets) is checked for conclusiveness. These
input/output relationships are easily acquired literature data (e.g. ”salt stress in-
duces expression of the ENA1 gene in yeast”44), and they can give a reasonable clue
if the model transmits the signal realistically. If the input signals are not activating
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the correct output nodes, the network needs to be scanned for loops and knowl-
edge gaps.
I have exemplified the workflow on the Snf1 pathway in yeast, which is activated
under glucose deprivation (and several other stresses) of the cell. By employing
the workflow, I was able to identify several knowledge gaps, which were filled with
hypotheticals to ensure signal transmission. After iterative rounds of model re-
finement, I could verify mechanistic connections between 4 input signals (glucose
and nitrogen starvation, alkaline pH value, and salt stress) and 7 output nodes for
transcriptional regulation. Several of these transcriptional outputs directly affect
metabolism and can thus verify that cells under stress imposemetabolic alterations
via signalling cascades. This finding is by no means a revelation, but it is a proof of
concept for the introduced workflow.
In summary, we could establish a connection from extracellular stress signals
over the Snf1 pathway to genetic regulatory elements. The Boolean modelling ap-
proach overcomes the major obstacle of modelling signalling pathways, the lack of
experimental data. Furthermore, we could point out, where gaps in the current
knowledge about the Snf1 pathway lie and where we need to direct future experi-
ments to close the gap between extracellular signals and gene regulation. Finally,
we provide a novel workflow that enables researchers to apply the same analysis
for other pathways of interest.
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Network reconstruction and validation of the Snf1/AMPK
pathway in baker’s yeast based on a comprehensive
literature review
Authors: Timo Lubitz, Niek Welkenhuysen, Sviatlana Shashkova, Loubna Bendri-
oua, Stefan Hohmann, Edda Klipp, and Marcus Krantz
Journal: This article has been published in NPJ Systems Biology and Applications,
2015
Accessiblity: It can be accessed online via doi:10.1038/npjsba.2015.7
Abstract
OBJECTIVES: The SNF1/AMPK protein kinase has a central role in energy home-
ostasis in eukaryotic cells. It is activated by energy depletion and stimulates pro-
cesses leading to the production of ATP while it downregulates ATP-consuming
processes. The yeast SNF1 complex is best known for its role in glucose derepres-
sion.
METHODS: We performed a network reconstruction of the Snf1 pathway based
on a comprehensive literature review. The network was formalised in the rxncon
language, and we used the rxncon toolbox for model validation and gap filling.
RESULTS: We present a machine-readable network definition that summarises
the mechanistic knowledge of the Snf1 pathway. Furthermore, we used the known
input/output relationships in the network to identify and fill gaps in the informa-
tion transfer through the pathway, to produce a functional network model. Finally,
we convert the functional network model into a rule-based model as a proof-of-
principle.
CONCLUSIONS: The workflow presented here enables large scale reconstruc-
tion, validation and gap filling of signal transduction networks. It is analogous to
but distinct from that established for metabolic networks. We demonstrate the
workflow capabilities, and the direct link between the reconstruction and dynamic
modelling, with the Snf1 network. This network is a distillation of the knowledge
from all previous publications on the Snf1/AMPK pathway. The network is a knowl-
edge resource for modellers and experimentalists alike, and a template for similar
efforts in higher eukaryotes. Finally, we envisage the workflow as an instrumental
tool for reconstruction of large signalling networks across Eukaryota.
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2.1.2 Dealing with knowledge gaps of signalling pathways
Knowledge gaps in signalling pathways are large obstacles for every modelling
effort. If a signal is not correctly transmitted throughout the model, the results
will not be adequate. With the workflow introduced in the previous chapter I could
identify new and verify old knowledge gaps in the yeast Snf1 pathway. One of the
major issues is the mechanistic activation of Snf1 by glucose deprivation, a process
that remains elusive. Step 5 of our workflow proposes means of dealing with such
gaps: To ensure full connectivity of the reconstruction, hypotheticals can be added
as place-holders to enable signal transmission. But this can only be a temporary
solution until new experiments are directly targetted at this specific gap to offer
new insight; an undertaking that is described in this chapter.
The activation of the Snf1 complex underlies a complex regulation. The involved
components are protein kinases, phosphatases, and other regulatory elements. I
have created 24 candidate ODE models, each representing a hypothesis for Snf1
complex activation. The models provide a time-resolved simulation of Snf1 activa-
tion and thus a more thorough insight into the system than a Boolean model. Ac-
cording to our experimental data and a discriminative parameter fitting, the most
likely candidate model in accordance to the given data represents the following
hypotheses:
The regulation of Snf1 phosphorylation is likely to be carried out by both kinase
and phosphatase, not by one of them exclusively.
The phosphatase that regulates Snf1 dephosphorylation (protein phosphatase 1)
is unlikely to be responsible for the localisation or dephosphorylation of the
Snf1 main target suppressor, Mig1.
It seems highly likely that there is a second glucose-regulated step between the
activation of Snf1 and the dephosphorylation (and thus inactivation) of re-
pressor Mig1.
The conclusions drawn from the results mainly hint for the second glucose-
regulated step that follows Snf1 activation. Until today, several hypotheses have
been stated about this particular step, but they could not explain the mechanistic
detail for Snf1 activation by glucose derepression. Nevertheless, with the presented
results we have improved our knowledge about Snf1 activation, and this is a small
but crucial step towards closing the gaps in the way from this extracellular signal
to gene regulation changes.
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Glucose de-repression by yeast AMP-activated protein
kinase SNF1 is controlled via at least two independent steps
Authors: Raul Garcıa-Salcedo, Timo Lubitz, Gemma Beltran, Karin Elbing, Ye Tian,
Simone Frey, Olaf Wolkenhauer, Marcus Krantz, Edda Klipp, and Stefan Hohmann
Journal: This article has been published in FEBS Journal, 2014
Accessiblity: It can be accessed online via doi:10.1111/febs.12753
Abstract
The AMP-activated protein kinase, AMPK, controls energy homeostasis in eukary-
otic cells but little is known about the mechanisms governing the dynamics of its
activation/deactivation. The yeast AMPK, SNF1, is activated in response to glucose
depletion and mediates glucose de-repression by inactivating the transcriptional
repressor Mig1. Here we show that overexpression of the Snf1-activating kinase
Sak1 results, in the presence of glucose, in constitutive Snf1 activation without al-
leviating glucose repression. Co-overexpression of the regulatory subunit Reg1 of
the Glc-Reg1 phosphatase complex partly restores glucose regulation of Snf1. We
generated a set of 24 kinetic mathematical models based on dynamic data of Snf1
pathway activation and deactivation. The models that reproduced our experimen-
tal observations best featured (a) glucose regulation of both Snf1 phosphorylation
and dephosphorylation, (b) determination of theMig1 phosphorylation status in the
absence of glucose by Snf1 activity only and (c) a regulatory step directing active
Snf1 to Mig1 under glucose limitation. Hence it appears that glucose de-repression
via Snf1-Mig1 is regulated by glucose via at least two independent steps: the con-
trol of activation of the Snf1 kinase and directing active Snf1 to inactivating its target
Mig1.
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2.2 Enzymatic regulation of
metabolic function
2.2.1 The evolution of enzyme kinetics
In the previous chapter, we have established a modelling connection between
extracellular signals and gene regulation. For this chapter, we are taking a re-
sulting change in gene expression as prerequisite. Now that a signal has caused
alterations in the gene expression of the cell, some protein levels are raised and
others diminished. These changes have direct effects on cell metabolism: Some
proteins impose allosteric regulation on cell compounds and thus cause changes
in their reactivity. Others are enzymes with a direct effect on the rate of metabolic
reactions. Now, the question arises how these regulatory effects can be modelled
and analysed accurately.
The modelling of cell metabolism requires the consideration of numerous regu-
latory principles and implications. This includes different enzyme kinetics and the
related difficult choice of kinetic rate laws for themodelled reactions; the incorpo-
ration of experimental data with emphasis on todays high throughput techniques;
parameter acquisition and determination; and finally the means of validating the
model with respect to parameter sensitivity, identifiability, and their confidence
intervals. These technical prerequisites are reviewed in this chapter, and can be
considered the foundation of the exhaustive metabolic modelling workflow of the
next chapter.
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New types of experimental data shape the use of enzyme
kinetics for dynamic network modeling
Authors: Katja Tummler*, Timo Lubitz*, Max Schelker, and Edda Klipp
Journal: This article has been published in FEBS Journal
Accessiblity: It can be accessed online via doi:10.1111/febs.12525
* These authors contributed equally to this work
Abstract
Since the publication of Leonor Michaelis and Maude Menten’s paper on the reac-
tion kinetics of the enzyme invertase in 1913, molecular biology has evolved tremen-
dously. New measurement techniques allow in vivo characterization of the whole
genome, proteome or transcriptome of cells, whereas the classical enzyme essay
only allows determination of the two Michaelis–Menten parameters V and Km .
Nevertheless, Michaelis–Menten kinetics are still commonly used, not only in the in
vitro context of enzyme characterization but also as a rate law for enzymatic reac-
tions in larger biochemical reaction networks. In this review, we give an overviewof
the historical development of kinetic rate laws originating fromMichaelis–Menten
kinetics over the past 100 years. Furthermore, we briefly summarize the experi-
mental techniques used for the characterization of enzymes, and discuss web re-
sources that systematically store kinetic parameters and related information. Fi-
nally, describe the novel opportunities that arise from using these data in dynamic
mathematical modeling. In this framework, traditional in vitro approaches may be
combined with modern genome-scale measurements to foster thorough under-
standing of the underlying complex mechanisms.
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2.2.2 Creating large-scale kinetic models of metabolism
Properly calibrated kinetic networkmodels are a practical tool to identify knowl-
edge gaps in silico and direct subsequent experiments, which is a comparable ap-
proach to what was introduced in the previous chapter about signalling pathways.
Although such a model is just an abstract representation of in vivo metabolism, it
can well identify poorly characterised parts of the pathway. Besides the consider-
ation of technical prerequisites in the previous chapter, also the construction of a
kinetic metabolic model in practise is not trivial. With growing model complexity,
kinetic parametrisation renders more and more infeasible: Too many parameters
have not been determined by experiments, cannot be determined, or have been
determined but are not available to the modeller. Thus, Systems Biology requires
newworkflows for the construction of large-scale kineticmodels, which can on the
one hand grow in size, but on the other hand do not lose in terms of sensitivity and
confidence. This raises the importance of sophisticated approaches for data aug-
mentation to deal with fragmentary kinetic parameter collections. Furthermore,
adding enzymatic regulation to the model dynamics requires experimental data as
well as a sound choice of rate laws to not corrupt themodel’s stability. This chapter
is focused on how these diverse but interconnected problems can be addressed in
order to construct a large-scale dynamic model of metabolism.
We have established aworkflow for large-scale kineticmodelling and introduced
it on the example of yeast metabolism. The model structure and stoichiometry is
extracted from a genome-scale model of yeast metabolism. Referring to the ques-
tions raised in the previous chapter, our workflow comprises: (i) the choice of a
common modular rate law for the reactions rate laws (a generalised form of the
reversible Michaelis-Menten kinetics applicable to any reaction stoichiometry), (ii)
a parametrisation via collected literature data and data augmentation with param-
eter balancing (ensuring thermodynamic consistency), and finally (iii) a sensitivity
and metabolic control analysis of the model to ensure a realistic behaviour under
perturbations of extracellular nutrients and enzyme concentrations. The result-
ing model shows realistic metabolic fluxes and can be directed to a desired steady
state, which is also stable in response to system perturbations. So far, there was no
Systems Biology workflow ensuring these accomplishments for large-scale meta-
bolic models. Finally, we figure that the step-by-step description of the workflow
for yeast metabolism will enable its unproblematic application to other organisms.
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Systematic Construction of Kinetic Models from
Genome-Scale Metabolic Networks
Authors: Natalie J. Stanford*, Timo Lubitz*, Kieran Smallbone, Edda Klipp, Pedro
Mendes, and Wolfram Liebermeister
Journal: This article has been published in PLOS One, 2014
Accessiblity: It can be accessed online via doi:10.1371/journal.pone.0079195
* These authors contributed equally to this work
Abstract
The quantitative effects of environmental and genetic perturbations on metabo-
lism can be studied in silico using kinetic models. We present a strategy for large-
scalemodel construction based on a logical layering of data such as reaction fluxes,
metabolite concentrations, and kinetic constants. The resulting models contain
realistic standard rate laws and plausible parameters, adhere to the laws of ther-
modynamics, and reproduce a predefined steady state. These features have not
been simultaneously achieved by previous workflows. We demonstrate the advan-
tages and limitations of the workflow by translating the yeast consensus metabolic
network into a kinetic model. Despite crudely selected data, themodel shows real-
istic control behaviour, a stable dynamic, and realistic response to perturbations in
extracellular glucose concentrations. The paper concludes by outlining how new
data can continuously be fed into the workflow and how iterative model building
can assist in directing experiments.
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2.3 Signals, genes, and metabolism:
Towards a holistic view
The two routes from a signal to gene regulation and from gene expression to
metabolism were the focuses of the previous chapters. But although I have intro-
duced large-scale modelling approaches for both signalling pathways and meta-
bolism, Systems Biology demands a more holistic view on the system. This can be
achieved by taking into account different layers of regulation not subsequently, but
simultaneously. First of all, this requires experimental approaches sophisticated
enough to provide us with simultaneous data from different cellular subsystems.
And even if this can be achieved, we need ideas how to incorporate these data into
one conclusive mathematical model. This chapter deals with this exact scenario.
Within this project, we are elucidating metabolic reprogramming in colorec-
tal cancer cells. It has been shown that metabolic features of cancer cells differ
strongly to these of normal cells. To investigate these features, I am provided with
a set of heterogenous experimental data types, i.e. 13C label incorporation data of
metabolic observables for different time points, label-free measurements of 4000
genes using shot-gun proteomics, and phosphorylation patterns of key players in
signalling cascades via a BioPlex system. These experimental approaches, all per-
formed on the same cancer cell lines in wild type and with mutations of two com-
mon oncogenes, are the basis for a complex analysis of the regulatory patterns of
cancer cells. As a starting investigation, I have employed the labelled isotope data
for nonstationary metabolic flux analyses (MFA) of glycolysis, TCA-cycle, and glu-
taminolysis for all used cell lines. This approach allows the determination of me-
tabolic fluxes from transient isotope labelling experiments. The accuracy of these
analyses was tested by assessing the goodness of fit of themodels. TheMFA results
confirm known behaviours of cancer cells, as well as identify novel findings.
The most interesting findings show the dependence of certain metabolic be-
haviours on the KRAS protein. The MFA suggests that cells with a mutated KRAS
oncogene fail to accumulate lactic acid, which is one of the key features of the
Warburg effect in cancer cells. Furthermore, cells bearing this mutation route car-
bon from 13C glutamine into the reductive part of the TCA cycle. These results
are augmented by analysing the proteomic and phosphoproteomic data of the cell
lines and by inferring connections between the subsystems. Understanding these
underlying principles is a crucial step in the identification of potential drug tar-
gets. To augment our analysis beyond the capabilities of a metabolic flux analysis,
we propose means of improving the experimental as well as the theoretical side
of this project by increasing measurement observables and explicitly suggesting
modelling techniques, which incorporate more of the provided data.
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Carbon tracking in colorectal cancer cells reveals novel
influences of the KRAS and BRAF oncogenes on
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Abstract
The regulatory principles of cancer cells are differing in many aspects from those of healthy
cells: Metabolic activity is reprogrammed by oncogenes and their direct and indirect influences
on metabolic enzymes and metabolites. Cancer cells favour aerobic and anabolic processes,
mostly independent of growth factor availability and cellular oxygen levels. Understanding these
changed features is a key aspect to cancer treatment. We are approaching this aim by investi-
gating the behaviour of colorectal cancer cells with cutting edge experimental techniques (13C
carbon tracing with the pSIRM workflow) and mathematical modelling approaches (metabolic
flux analysis), which reveals novel causes of metabolic reprogramming. We suggest the KRAS
protein to be responsible for lactic acid accumulation in cancer cells and we narrow down the
search for responsible participants of this effect with proteomic and phosphoproteomic data.
Furthermore, proteins BRAF and KRAS both appear to be responsible for the employment of
the reductive TCA cycle in glutaminolysis. Finally, we are proposing targets for future experi-
ments and further mathematical modelling approaches for cancer cell metabolism.
Introduction
Colorectal cancer has the third highest fre-
quency among tumors in developing countries
with approximately one million new cases per
year [1]. The disease arises from an imbalance
in differentitation, proliferation, and apoptosis
of the epithelium triggered by specific muta-
tions. Up to 50% of patients harbor a mutation
in the KRAS oncogene. Beside RAS activa-
tion of downstream signalling cascades, which
are important for several cell processes, stud-
ies have shown the importance of metabolic
changes induced by oncogenic KRAS [2, 3]:
Metabolic deregulation is one of the new hall-
marks in cancer shown by Hanahan and Wein-
berg [4, 5]. Several reports show that nutri-
ent uptake and metabolic alterations are un-
der control of the RAS protein, leading, for in-
stance, to changes in glucose and glutamine
consumption [6], increased glycolysis [7], and
induction of de novo lipid synthesis [8, 9] (see
Figure 1 for an overview of metabolic repro-
1
2Figure 1: Influences of the RAS oncogene on metabolism. The RAS protein regulates many enzymatic targets in
central carbon metabolism and is responsible for metabolic reprogramming in cancer cells. The depicted reactions are
only an extract of RAS targets in central carbon metabolism. Dashed lines represent clustered reactions.
gramming induced by RAS in cancer cells). In
addition to KRAS mutations, BRAF mutations
occur in approximately 10% of colorectal can-
cer cells and are witnessed in almost all col-
orectal tumors with wildtype KRAS. Data im-
plicates that around 50% of patients harbor-
ing no mutation in KRAS could benefit from
an anti-EGFR therapy. Nevertheless, 40-60%
of patients with wildtype KRAS do not respond
to the treatment [1]. Advances in drug devel-
opment over the last decades have expanded
the number of potential therapies, but these ur-
gently require optimisation. Therefore, under-
standing the underlying biology of how colorec-
tal tumors form and progress is important for
developing effective personalised therapies for
patients with this disease.
We aimed at investigating cell morphol-
ogy alterations upon stable expression of both
oncogenes over time. Since oncogenes can in-
duce a metabolic switch, we further analysed
the effect of nutrient changes in cells express-
ing mutant BRAF and KRAS proteins. We used
Caco-2 cells, which were stably transfected
with inducible BRAF or KRAS. The Caco-2 cell
line is a commonly used model for analysing
human intestinal epithelium. The cells are
known to be capable of spontaneous differen-
tiation under standard conditions in vitro and
harbor enterocyte-like structural and functional
characteristics [10].
We are employing the recently intro-
duced pSIRM workflow (pulsed stable isotope-
resolved metabolomics [11]), which allows for
the direct measurement of dynamic metabolic
activity by tracing the flux of 13C glucose, 13C
glutamine, or other labelled isotopes through-
out the central carbon metabolism. The result-
ing mass isotopomer distribution vectors can
be employed for an instationary metabolic flux
analysis (MFA [12, 13]), which quantitatively
determines the metabolic fluxes of the system
(for an overview of the technique see Figure
2). The pSIRM approach is extended for shot-
gun proteomic sequencing and BioPlex deter-
mination of phosphoproteomics to investigate
3the causes of metabolic deregulation. Employ-
ing these diverse data for a systematic analysis
is a prerequisite for the identification of poten-
tial genetic targets for the optimisation of a spe-
cific phenotype [14] or for metabolic alterations
upon the change of environmental conditions
and genetic modifications [15, 16].
We were able to verify known and dis-
cover novel features about the connection of
BRAF and KRAS proteins to lactic acid pro-
duction, as well as to the occurrence of re-
ductive TCA cycle in glutaminolysis. Still, we
are far from understanding how the microen-
vironment modulates tumor heterogeneity and
drives the phenotypic behaviour of a tumor cell
population, but high throughput technologies,
such as proteomics and metabolomics, aim at
a global molecular description of complex cel-
lular behaviour. Metabolic profiling in combina-
tion with sophisticated mathematical modelling
approaches enables the comparison of normal
and mutated cells, which can be used to identify
new biomarkers and support for cancer diagno-
sis and treatment.
Methods
Cell culture The Caco-2 cell lines were
kindly provided by Dr. Tilmann Brummer
(Institute of Molecular Medicine and Cell
Research Freiburg). Caco-2tet cells and
their derivates Caco-2tet/empty vector, Caco-
2tet/BRAFV 600E , and Caco-2tet/KRASG12V
have been described previously [17, 18]. Also,
the doxycycline inducible expression system is
described in detail elsewhere [19]. The cells
were incubated in a humified atmosphere of
5% CO in air at 37◦ Celsius and cultivated
in glucose-free Dulbecco’s modified Eagle’s
medium (DMEM, Life Technologies, #A14430-
01), supplemented with 10% fetal bovine
serum (GIBCO), and 1% penicillin/streptomycin
(GIBCO), 4 mM glutamine (GIBCO), 1 g/l glu-
cose, 2 µg/ml doxycycline, 5 µg/ml puromycin,
and 5 µg/ml blasticidin. After seeding, the cells
were cultured with a stable addition of doxycy-
cline over time to induce KRAS/BRAF expres-
sion. Cells were preincubated for 3 days in 1g/l
glucose, plated and lysed after 48 h.
pSIRM We employed the pSIRM workflow
(pulsed stable isotope-resolved metabolomics
[11]), to measure the dynamic metabolic ac-
tivity through central carbon metabolism. The
approach allows the measurement of time-
resolved isotopic enrichment and a quantifica-
tion of metabolites within a single measure-
ment. Thus, the metabolites closer to the origi-
nating substrate will have a higher isotope label
incorporation than those further downstream.
The measured observables are glucose 6-
phosphate, glyceraldehyde 3-phosphate, ser-
ine, pyruvic acid, lactic acid, alanine, citric acid,
fumaric acid, and malic acid for [u13C] glu-
cose incorporation (at time points 2, 5, and 8
minutes). For measurements with [u13C] glu-
tamine, the observables are glutamic acid, α-
ketoglutaric acid, succinic acid, fumaric acid,
malic acid, and the 276 and 278 isoforms of cit-
ric acid (at time points 5, 15, and 45 minutes).
For a thorough method description the reader
is referred to the original publication introduc-
ing the pSIRM workflow [11].
The approach has been extended for the
simultaneous determination of label-free pro-
teomic quantities by shotgun sequencing [20]
and of phosphoproteomic data acquired by the
BioPlex technology (data not shown).
Instationary MFA Metabolic flux analysis
(MFA) is a fluxomics technique for estimating
the metabolic fluxes of a system on the grounds
of experimental data. Based upon stable iso-
tope 13C data, MFA aims at quantifying the inte-
grated responses of metabolic networks to sys-
tem changes [12]. The approach can be ex-
4Figure 2: Workflow for metabolic flux analyses MFA studies are carried out by feeding cells an isotopically labelled
substrate (here, 13C-labeled glucose and glutamine) and measuring the patterns of isotope incorporation that emerge in
downstream metabolites using mass spectrometry. A computational model of the intracellular metabolic network is used
to determine pathway fluxes by integrating these isotope labelling data. The results can be used for iterative rounds of
experiments and simulations. Finally, MFA reconstructs comprehensive flux maps depicting cell metabolism.
tended by employing transient isotope labelling
experiments, which yields an isotopically non-
stationary MFA [13].
Mathematically, MFA is an optimisation
search for the identification of flux parameters
and pool sizes, which minimise the sum-of-
squared residuals (SSR) between the experi-
mentally derived data and the computationally
simulated data [21]. At each iteration of the
optimisation, the objective function is solved to
simulate the measured isotopomer distributions
on the basis of the metabolic network and a set
of parameter estimates. The inverse problem
can be expressed as
max
u,c,h
Φ = rT ·
∑
−1
·r
subject toK · u ≥ 0, c ≥ 0, h ≥ 0.
To determine the minimal distance be-
tween computational simulation and experi-
mental data, the objective function Φ needs to
be maximised. First, the determination of the
measurement vector m is required, which is a
general function of the fluxes u, the pool sizes
c, and time t. Thus, m comprises all simula-
tions of fluxes, pool sizes, and mass isotopomer
distributions, for which experimental measure-
ments are available. In a second step, by incor-
porating an MS scaling factor h for the renor-
malisation of mass distribution vectors [22], the
residual vector r can be calculated from m as
r = m(u, c, h, t)− mˆ(t), (1)
where mˆ(t) is the experimental measure-
ment vector. Now, Φ can be maximised over
r and the diagonal weighing matrix
∑
−1
= diag(σ), yielding the optimal flux dis-
tribution for the metabolic network in terms of
the experimental data. For detailled reviews on
MFA the reader is referred to [21] and [23].
All models are available as MATLAB [24]
model structure and flux map files.
5Goodness of Fit After performing a
metabolic flux analysis, it is of utmost impor-
tance to assess the goodness of the fit to
evaluate the accuracy of the analysis. This
test is based on the assumption that the SSR
achieved by the objective function follows a χ2
distribution [25] with n − p degrees of freedom
(where n is the number of independent exper-
imental measurements and p the number of
parameters that are fitted). If the fit is rejected,
either the model or data are likely to comprise
inconsistencies that need to be reevaluated be-
fore proceeding. For a proper description of
the method the reader is refered to Riedwyll et
al. [26]. For the MFA and the goodness-of-fit
analysis, we were using the MFA-INCA toolbox
[27].
Results
KRAS protein induces lactic acid accumula-
tion The paths of the labelled carbon atoms
after 13C glucose incorporation can be fol-
lowed throughout glycolysis and the TCA cycle.
The corresponding label incorporations are de-
picted in Figure 3 (A). Furthermore, Figure 3 (B)
shows the metabolic models designed for the
metabolic flux analysis: All measured metabo-
lites are incorporated and the fluxes are en-
abled to branch into sinks. Figure 3 (C) displays
the goodness of fit for the metabolic flux analy-
ses.
The carbon routing pattern is similar for
all three cell lines. As expected, the largest
amounts of isotope labelled carbon is routed
through glycolysis, without branching signifi-
cantly into the serine synthesis branch. Over
the branching point pyruvic acid, the carbon is
distributed in different branches of metabolism:
In both the control and Caco-2 BRAFV 600E
cell lines, about 50% of the introduced car-
bon branches into the production of lactic acid.
Furthermore, large quantities are employed for
the synthesis of alanine (18.99% in control and
31.88% in BRAFV 600E cells).
Regarding the pyruvate branching point,
Caco-2 KRASG12V cells show significant dif-
ferences to the other two cell lines. The pro-
duction of lactic acid is decreased significantly,
while the production of alanine precursors has
increased to a similar degree at which lac-
tic acid production is decreased. Finally, the
rest of the labelled carbon is routed through
the TCA cycle, where no measurable branches
could be identified by the analysis. The assess-
ment of the goodness of the fits (see Figure
3 (C)) verifies that the metabolic flux analysis
results were accepted, although some outliers
are situated around the simulation line of the
weighing results.
The reductive TCA cycle in glutaminoly-
sis is employed by mutations in BRAF
and KRAS Cells fed with 13C glutamine sub-
strates are routing the labelled carbon directly
into glutaminolysis. Glutamine is converted to
glutamic acid, which then enters the mitochon-
drion; the carbon can be tracked throughout the
TCA cycle. We are able to determine whether
the introduced carbon is routed into the reduc-
tive or the oxidative TCA cycle by examining
the mass isotopomer distribution vector of cit-
ric acid: Depending on the positions of the la-
belled carbon atoms, it can stem (i) from gly-
colysis, (ii) the oxidative TCA cycle, or (iii) from
the reductive TCA cycle. Since the introduced
13C glutamine excludes a significant amount of
citric acid synthesised from glycolysis (i), we
distinguished between the two citric acid iso-
forms stemming from oxidative (ii) and reduc-
tive TCA cycle (iii). Figure 4 depicts the exper-
imentally derived label incorporations (A), the
corresponding metabolic flux analyses (B), and
the goodness of fit for the analyses (C) of the
three different cell lines.
Similar to the glucose experiments, the label
6Figure 3: Carbon tracking with 13C glucose. (A) Experimentally derived label incorporation in central carbon
metabolism after addition of 13C glucose. The different colours correspond to the used cell lines, the histograms depict
the incorporation for the measured time points. (B) The metabolic fluxes as simulated by MFA. The fluxes are estimated
on the grounds of experimental data, in this case 13C glucose isotope-resolved metabolomics. (C) Goodness of fit for the
MFA. This technique gives an estimate about the accuracy of the corresponding metabolic flux analysis.
7incorporation of the three cell lines is similar for
most reaction routes. Glutamine is converted to
glutamic acid and enters the TCA cycle via α-
ketoglutaric acid. The control cell line routes all
carbon in the oxidative TCA cycle, but branches
50% of it out via fumaric acid. While this branch
remains constant among all used cell lines, the
Caco-2 BRAFV 600E cells direct a small amount
of carbon to the reductive TCA cycle (3.61%),
and the Caco-2 KRASG12V cells even 14.4%.
The assessment of the goodness of fits, Figure
4 (C), allows the inference of conclusions about
the accuracy of the analyses. While the quality
of the fits as a whole is located within the ac-
ceptance boundaries, all three cell lines show
some outliers in the bottom left of the fit visual-
isations.
Discussion
KRAS and BRAF are responsible for
metabolic reprogramming The examined
cancer cell lines show characteristics of
metabolic reprogramming dependent on the
oncogenes KRAS and BRAF. Cancer cells are
known to accumulate lactic acid as a com-
pensation for increased glucose uptake [28].
Our experiments show the direct connection
to an important player of growth factor sig-
nalling, the GTPase KRAS: In Caco-2 cells with
a G12V mutation of the KRAS gene, lactic acid
is not accumulating as in Caco-2 wild type or
BRAFV 600E cells. It can be concluded that a
mutation of the KRAS gene either leads to se-
vere effects on downstream signalling targets
of KRAS protein or the mutated protein has a
direct influence on metabolic function. Recent
studies support the theory that activated onco-
genes often reprogram cellular metabolism in
a direct manner, instead of interfering with sig-
nalling cascades [4]. Moreover, our flux anal-
yses show a high amount of carbon routed
to the synthesis of alanine in all three cell
lines, which has been shown in previous stud-
ies [29, 30, 31].
We were also able to analyse features of
cellular glutaminolysis. When fed with 13C glu-
tamine, all cell lines showed a high leakage
of labelled carbon from oxidative TCA cycle
via the branching point fumaric acid. This oc-
currence has been shown previously in can-
cer cells and is likely caused by mutations in
the fumaric acid hydratase (FH) and the suc-
cinate dehydrogenase (SDH). This causes an
accumulation of fumaric acid and succinic acid,
which is compensated by the production of suc-
cinic acid glutathione [32, 33].
Finally, while the Caco-2 control cell line,
provided with 13C glutamine, routes the labelled
carbon entirely through the oxidative TCA cy-
cle, Caco-2 BRAFV 600E cells direct a small
amount of it in the reductive cycle. This amount
is even increased in Caco-2 KRASG12V cells,
which has been shown before for cancer cells
[34]. The stepwise increased carbon amount
in the two cell lines proposes a multicausal ef-
fect. While the BRAFV 600E mutation already
employs the reductive TCA cycle, this is am-
plified by a KRAS mutation. Similar to the lactic
acid production in the other experiments, the
various downstream targets of KRAS protein
are potential contributors to this amplification
from BRAF to KRAS mutant.
Augmenting the results by proteomic and
phosphoproteomic data The metabolic
fluxes give an accurate description of how can-
cer cell metabolism is reprogrammed in con-
trast to normal cells. However, while the repro-
gramming effects in cancer cells become more
and more clear (see Figure 1), the dependency
of these effects on oncogenes often remains
elusive. These dependencies can only be stud-
ied accurately by simultaneous measurements
of other regulatory cell structures. Thus, we
are augmenting our findings so far towards a
8Figure 4: Carbon tracking with 13C glutamine (A) Experimentally derived label incorporation in the TCA cycle after
addition of 13C glutamine. The different colours correspond to the used cell lines, the histograms are depict the incor-
poration for the measured time points. (B) The metabolic fluxes as simulated by MFA. The fluxes are estimated on the
grounds of experimental data, in this case 13C glutamine isotope-resolved metabolomics. (C) Goodness of fit for the
MFA. This technique gives an estimate about the accuracy of the corresponding metabolic flux analysis.
9more holistic view on the regulatory principles
of the system. The proteomics analysis (un-
published data not shown here) could identify
genes SLC2A3 and SLC2A14, members of the
glucose transporter family GLUT, to be severely
underexpressed in KRASG12V cells in compari-
son to the other used cell lines, which coincides
with earlier studies [35]. The enzyme lactate
dehydrogenase A (LDHA), which is responsi-
ble for the conversion of pyruvate to lactic acid,
showed decreased concentration levels in the
KRASG12V cells. This is in agreement with
the decreased lactic acid concentrations in this
cell line. There were no significant changes
in the concentration levels of lactate dehydro-
genase B (LDHB), which also underlines the
hypothesis that certain cancer forms prefer dif-
ferent enzyme isoforms over others [36, 37].
Furthermore, this is contradictory to an effect
witnessed in lung cancer cells, which show the
linkage of LDHB to the KRAS oncogene [38].
The phosphoproteomic data (unpublished
data not shown here) provides a view on the
phosphorylation patterns of the downstream
targets of KRAS protein. KRAS triggers a va-
riety of signalling pathways, which are mostly
transmitting growth factor signals. Our data
exclude the RAS/MAPK pathway as potential
cause of the lactic acid accumulation: Since
the increased lactic acid production is not tem-
pered in BRAFV 600E cell lines, it is unlikely
that the RAS/MAPK pathway, which employs
BRAF protein, is responsible for the witnessed
effect [39]. Other KRAS downstream targets
include PI3K (cell survival, growth, diverse
transcription factors), RALGDS (endocytosis),
mTOR, Protein kinase B, and several other
frequented compounds. The phosphorylation
patterns revealed changes for Protein kinase
B (and its downstream targets NF-κB, mTOR,
and p70S6). These alterations suggest that this
signalling pathway is frequented differently than
in the other cell lines, thus giving rise to the as-
sumption that it is involved in the changed be-
haviours of the cell, i.e. decreased lactic acid
production.
In the analysis of the reductive TCA cycle
effects in glutaminolysis, we are again led to
either direct or downstream targets of KRAS
protein. But here, we cannot exclude the
RAS/MAPK pathway, since the BRAFV 600E cell
lines already show carbon routing through the
reductive TCA cycle. On the contrary, we
must explicitly include downstream targets of
the RAS/MAPK pathway, and extend this list by
targets of the other KRAS-induced pathways.
Intuitive targets are the enzymes solely em-
ployed for reductive TCA (ATP citric acid lyase,
2-oxoglutarate:ferredoxin oxidoreductase, and
pyruvic acid:ferredoxin oxidoreductase). Here,
we can exclude the ATP citric acid lyase, which
is responsible for the synthesis of acetyl-CoA
and oxaloacetate from citric acid. Our pro-
teomics data suggest that there are no shifts in
gene expression for this enzyme in our different
cell lines.
Directing future research Our data highlight
the complexity of the metabolic reprogramming
of cancer cells. Experimentally, this suggests
further sensibly chosen targets to better nar-
row down the amount of potential causes for
the witnessed scenarios. (i) A reasonable ex-
tension of metabolic observables can improve
the analyses of metabolic fluxes. We rec-
ommend more metabolic targets that are situ-
ated around complex branching points of cen-
tral carbon metabolism, such as glucose 6-
phosphate (branching to pentose phosphate
pathway) and pyruvic acid (with routes to e.g.
lactic acid, alanine, acetate, acetaldehyde,
acetyl-CoA). (ii) Also, experimental interaction
studies of the KRAS and BRAF proteins with
the aforementioned enzymes can be of inter-
est, to test for direct interactions with LDH, 2-
oxoglutarate:ferredoxin oxidoreductase, or the
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pyruvic acid:ferredoxin oxidoreductase. Lastly,
(iii) phosphoproteomic targets downstream of
the Protein Kinase B pathway can narrow down
the search for potential candidates that cause
the witnessed metabolic deregulations.
As a technical consideration, the complexity
of the regulatory system and the heterogene-
ity of the experimental data requires a more
precise modelling approach than a classical
metabolic flux analysis. We have to aim for a
more advanced modelling approach to account
for potential candidates that cannot be uncov-
ered by flux analyses: The influence of the in-
tricately maintained NADP:NADPH balance of
the mitochondrion, for instance, can be a key
issue when analysing the displayed scenarios.
It is significant, since (i) the synthesis of lactic
acid by lactate dehydrogenase is coupled to the
conversion of NADPH to NADP [40]. Also, (ii)
α-ketoglutaric acid is reduced to isocitric acid
under the oxidation of NADPH to NADP, which
is in this case the initial step of the reductive
TCA cycle. The sensitive balance of these in-
volved co-factors demands for a more sophis-
ticated mathematical modelling approach than
a classical metabolic flux analysis. A recom-
mendable choice can be a model of ordinary
differential equations (ODEs) that allows a dy-
namic continuous simulation of the system and
displays the concentration changes over time.
Such a model can consider the balance of co-
factors as well as the thermodynamic feasibility
of reactions. The benefits of this approach have
to be earned by the provision with more exper-
imental data and refined parameter estimation
and data augmentation techniques. However,
these methods are available [41, 42] and ex-
perimental data can be provided as soon as
knowledge gaps and suitable targets are iden-
tified. With this work, we have aimed at provid-
ing suggestions for these gaps and targets at
numerous points of cancer cell metabolism.
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2.4 SBtab: An SBML-interconvertible
table format for data exchange
in Systems Biology
During the time of my doctoral studies, I have learned about the importance of
workflows and their reproducibility. A major prerequisite to a workflow is an ac-
curate description of the interface formats that are employed for data exchange
between the workflow steps. Standard formats are a useful approach for a seam-
less data exchange; they allow for the combination of software tools and can be
processed automatically. Chapter 1.2 offers a short summary on the merits of and
requirements for standard formats. However, the existing Systems Biology stan-
dard formats each have their shortcomings, like limitations to specific kinds of data,
some lack human-readability, others only target very distinct user groups. Fur-
thermore, some can only be used with technical knowledge or software expertise.
We have developed a new interface format - SBtab - which supports the ex-
change and automated processing of data tables. In general, SBtab files are data
tables comprising diverse kinds of information (e.g. lists of reactions, compounds,
parameters, etc.), which have to adhere to certain conventions and syntax rules.
They can be created with any text editor or spreadsheet tool (like MS Excel) and
examples for different predefined data types can be seen in Figure 2.1.
The effort of a new proposal for a standardised data format would be futile, if it
could not be processed automatically by software tools. Thus, we are providing a
set of versatile tools that facilitate the usage and improve the applicability of SBtab:
Online Validator To ensure that an SBtab file follows all defined conventions, users
can upload the file to our website www.sbtab.net. Here, SBtab files can be
displayed and automatically validated to test their syntactic correctness.
SBML Converter On the same website, SBtab files with model structure data can
be converted to SBML models and vice versa.
SQLite interface SBtab files can be used for the import and export of data into
and from an SQLite database. The database can be queried via standard SQL
queries, which are supported by most programming languages (this tool is a
courtesy of Dr. Elad Noor, ETH Zürich).
xlSBtab Excel Add-in The SBtab validator and SBML converter can also be used
from within Microsoft Excel via our Add-in called ”xlSBtab” (this tool is a
courtesy of Dr. Frank T. Bergmann, COS Heidelberg).
Python scripts Most SBtab tools are also available as Python scripts with easy in-
terfaces. This enables programmers to embed SBtab objects and correspond-
ing functions into their own software tools or workflows.
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Conclusion
With each chapter, this thesis has subsequently lead through diverse regular
subsystems of the cell. An extracellular signal has entered the cell and was trans-
duced over a signalling cascade down to gene regulation in Chapter 2.1. In the
following chapter 2.2, the changed gene expression patterns affected metabolic
functionality by the alteration of the cells’ protein composition. Finally, Chapter 2.3
approached amore holistic view of the cellular systemwith the focus on oncogene-
induced metabolic reprogramming in cancer cells. Figure 3.1 serves as a roadmap
for the interconnection of these different subsystems. It remains to be answered,
how the proposed modelling workflows contribute to the technical standards of
Systems Biology and how the projects’ results expand our understanding of the
targetted biological systems.
Exploring signalling pathways The mathematical modelling of signalling path-
ways (see left side of Figure 3.1) is an intricate field of research. The interactions
of cascade components are hard to measure and underlie highly complex and di-
versemechanisms (changes inmolecule structure, posttranslational modifications,
complex formations, andmore). Although the amount of experimental data for sig-
nalling pathways increases rapidly, data often is not sufficient for a detailled time-
resolved modelling of complete signal transductions from input signal to gene ex-
pression47. The most common modelling efforts of signalling pathways comprise
ODE models of comparably small-scaled systems48,49,50,51 and also serve network-
based methods for larger models52,53. Both approaches are justified for different
types of analysis, an aspect which I have illustrated within this thesis.
The large-scale modelling of signalling pathways is a growing field in Systems
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Figure 3.1: Regulatory layers of the cell. Left: Extracellular signals are received by the cell andtransmitted via signalling cascades. The information is passed down to the cells’ nucleus by sub-sequent protein modifications and the formation or breakup of protein complexes. In the nucleus,the activity of transcription factors is altered. Bottom: In response to transcription factor activ-ity changes, genes are activated or inhibited. This changes gene expression levels and thus theprotein composition of the cell. Right: The proteins are governingmetabolic functionality. De-pending on their expression levels, metabolism converts nutrients to energy and cellular buildingblocks.
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Biology. Samaga et al. present a thorough review on the currently employed for-
malisms, comprising interaction graphs, Boolean models, and logic-based ODEs54.
(i) Interaction graphs are suitable for a crude and first representation of the sys-
tem and they offer simplemeans for the analysis of the components’ dependencies.
This, however, limits their applicability: Realistic simulations are not feasible and
this eliminates the option of employing them for hypotheses testing. (ii) Boolean
models improve this analysis by adding logical combinations of edges and thusmo-
delling an important regulatory layer29,55. (iii) Logic-based ODEs can be fitted to
experimental data, but they do not add further information to the Boolean logic
implementation; they still must be considered phenomenological models56. The
dependence on experimental data makes logic-based ODEs an interesting option
for the future, but it cannot be the formalism for today. In light of these three ap-
proaches, we have decided to employ the Boolean solution for the investigation of
the Snf1 pathway.
Our introduced approach for constructing large-scale signalling network re-
constructions and validating their accuracy and connectivity with Boolean mo-
delling (see Chapter 2.1.1) is novel, flexible, and versatile. It excels from previ-
ous approaches by several features: The initial network reconstruction is based
on a manual curation of all publicly available Snf1 literature; the employed rxn-
con framework57 offers a sophisticated constraint-based modelling approach for
signalling networks; the iterative curation process of the Boolean model exposes
knowledge gaps of the pathway on the basis of verified input/output relationships
of the network; the final model can be exported into a rule-based representation,
which builds a bridge from Boolean to dynamic modelling. A bridge that is ur-
gently needed, since Boolean modelling may only be an interim solution for more
detailled and continuousmodelling efforts. The rule-basedmodel employs 176 dis-
tinct parameters, which shows where the next required steps in the modelling of
signalling pathways lie. More experimental data will give better insight into the
complex and diverse reaction cascades of these pathways, which will eventually
allow us to model them dynamically. Until then, reconstructive workflows like the
one presented here are the main tool for the exploration of pathways as a whole
and the direction of future experiments.
The application of the aforementioned workflow on the Snf1 pathway is the first
large-scale modelling effort of this otherwise well-analysed pathway. One of the
benefits of the workflow is the exposition of knowledge gaps, and the main gap in
the Snf1 pathway is the mechanistic activation of Snf158. For the analysis of this
crucial point, I have applied ODEs for the modelling of different hypothetic candi-
dates of Snf1 regulation (see Chapter 2.1.2). This process ofmodel discrimination on
the grounds of experimental data is not new59,60; but it is a powerful mathematical
approach for minimising the distance between computational simulation and real-
ity61. Furthermore, there is no mathematical modelling effort for this major part of
the Snf1 pathway available so far. And the results of the project still withstand: Our
suggestion of a second glucose-regulated step between the activation of Snf1 and
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the dephosphorylation of Mig1 has found several candidates in the recent years.
The SUMOylation and ubiquitylation of Snf1 by Mms21 and Slx5, respectively62, as
well as the binding of ADP to prevent Snf1 dephosphorylation63. The latter is a
coherence to the mammalian homologue of Snf1, AMPK, which is regulated by in-
tracellular levels of AMP. But although our findings have contributed to better our
understanding of the mechanism of Snf1 activation, we are still on the search for
more details of Snf1 regulation. This is a comprehensible effort, since AMPK, the
mammalian homologue of Snf1, is an important player in cellular stresses and dis-
eases. Mutations leading to a deregulation of AMPK are the cause of many human
lifestyle diseases, such as obesity, type 2 diabetes, cancer, and heart diseases64.
Thus, Snf1/AMPK is a significant target for regulating drugs and treating related
diseases. We need to understand the regulation of Snf1/AMPK activation in me-
chanistic detail in order to find starting points for drug development. This research
is further complicated by the fact that Snf1 is not only activated by glucose depriva-
tion, but also by a various line-up of other stresses, including salt stress, nitrogen
starvation, ultraviolet radiation, alkaline pH, and others. The presented results are
one more piece for solving the puzzle of Snf1 pathway regulation.
The intricate enzymatic regulation of metabolic models Just like the mathe-
matical modelling of signalling pathways, models of cellular metabolism (see right
hand side of Figure 3.1) differ in size, scope, and formalism65. The most common
approaches are ODE models for networks of a smaller scale and stoichioimetric
models for genome-scale implementations. While the beginning of the century
has brought several small and middle sized glycolysis and central carbon metabo-
lism models to light66,67,68, metabolomic and genomic data accumulated fast and
made way to first stoichioimetric genome-scale reconstructions of cell metabo-
lism69,70,71. The smaller models provide a detailled, but necessarily limited insight
into cell metabolism. Single reactions or chains of subsequent reactions can be
modelled fairly reliable, but they are only a glance through a possibly deceptive
keyhole. They neglect branches and interactions with other cellular components,
the employed parametersmay bemeasured under differing conditions (e.g. pH and
temperature), and these circumstances broaden the gap between in silico and in
vivo even further. In contrast, genome-scaled models do not offer a parametri-
sation at all due to their complexity. They can be employed for approaches like
elementary mode or flux balance analysis, which are efficient methods; but they
can only be a weaker alternative to dynamic continuous modelling. In between the
small and genome-scale models are the ever-growing and improving approaches
for large-scale kinetic modelling of metabolism72,73,74,26. All of them, however, need
to cope with the same obstacles of large-scale metabolic modelling, such as the
choice of kinetic rate laws, proper formulations of a biomass reaction, the avail-
ability and interpretability of experimental data, or the sensitivity of parameters.
Most of these questions are addressed by our review about the evolution of enzyme
kinetics (see Chapter 2.2.1) and an extensive review on the topic of large-scale mo-
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delling in yeast was introduced by Österlund et al.65. So far, these approaches have
been hampered by a lack of steady state or unrealistic behaviour against system
perturbations.
With our introduced workflow for large-scale kinetic modelling of metabolism
(see Chapter 2.2.2) we aim at overcoming the main obstacles of the field and the
presented yeast metabolism model shows significant improvements to previously
published models of the same size scale. The application of parameter balanc-
ing ensures thermodynamic feasibility and augments the fragmentary kinetic pa-
rameter set by employing parameter dependencies within a Bayesian framework.
Furthermore, differences in measurement conditions of the parameters can be ad-
justed. Our model reaches a steady state, which is stable against perturbations of
glucose concentration. Furthermore, the performedmetabolic control analysis re-
vealed a realisticmodel behaviour in response to changes in enzyme concentration.
All these features have been achieved with experimental and kinetic data from the
literature or approximative values, which stands for the prowess of the workflow
and gives an estimation of its capabilities if directed experimental data was applied.
It also shows that knowledge gaps can be addressed by approximative approaches
and well-grounded assumptions. But despite these improvements, it needs to be
duly noted that this is not a finished model. We are rather proposing a powerful
workflow for the creation of large-scale metabolic models, which can be extended,
iterated, and improved as soon as new experimental data becomes available. This
workflow for the creation of kinetic models can make them a powerful tool for in-
vestigating changes in enzyme concentration. For instance, in the FBA step of the
workflow, fluxes may be constrained to 0, representing gene knockouts, i.e. a loss
of enzymatic regulation. Until today, further steps have been taken in large-scale
modelling by incorporating the ensemblemodelling approach75,76; focussing on so-
phisticated parameter estimation techniques to overcome lack of kinetic data77,78;
combining dynamic and genome-scale approaches with hybrid techniques79; by
adding knowledge about the gene regulation module80; and finally, of course, by
the incorporation of more experimental data81. A recent review summarises these
latest achievements in large-scale kinetic modelling of cell metabolism in detail82.
It is important that metabolic models show realistic behaviours in order to be-
come meaningful tools in cellular research. Their simulation and application can
direct future experiments to gaps in our knowledge of the system. And under-
standing metabolism as a whole opens possibilities: Metabolic engineering, for
instance, supports the production of drugs (like insulin and antibiotics) or of re-
quired industrial chemicals (like shikimic acid)83 via sophisticated strain design
techniques84. But naturally, another reason for our longing to promote metabolic
research can be directly adapted from what has been said about signalling path-
ways: It is once more a potential starting point for drug therapy. Metabolism, as a
cellular subsystem, is different from signalling pathways, but the scope of this the-
sis should have shed light on the direct connection of the two. One cannot under-
stand one without the other, and if we want to thoroughly direct research towards
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the starting points of drug development, we need to understand metabolism just
as well as cell signalling. The sole focus on metabolism can show us how enzymes
control metabolic functionality, why certain nutrients cannot be metabolised, or
which metabolic reactions are responsible for the accumulation of metabolic by-
products, for example. But the background of this ”output” behaviour can only be
understood by taking a step back and regarding the larger, more holistic picture of
the cell.
Signalling proteins, gene regulation, and metabolism in a joint modelling ap-
proach Cancer cell metabolism urgently requires a holistic analysis, which com-
prises aspects from signalling pathways as well as oncogene regulation and me-
tabolism itself (see Figure 3.1). The behaviour of cancer cells is differing strongly
to that of normal cells. Their growth factor responses are constantly active, inde-
pendent of growth factor availability. They prefer aerobic glycolysis irregardless
of oxygen levels. Nutrition uptake is upregulated, which is compensated by the
accumulation and fermentation of lactic acid85. These are only some major dif-
ferences, which are complemented by many other metabolic deregulations. They
are mainly put into effect by oncogenes, which frequently encode proteins from
signalling pathways. But it cannot be inferred that signalling pathways are solely
responsible for this metabolic reprogramming of cancer cells. Instead, many of
the oncogene encoded proteins affect metabolic components in a direct manner
instead of altering the course of signalling cascades86,87. These coherences make
it inevitable to regard cancer cell metabolism in context with a proper analysis of
oncogenes and the signalling status of the cell.
To date, there are many different advances in the modelling of cancer-specific
systems. Like in normal cells, ODE models are a convenient tool for detailled sig-
nalling88,89, metabolic90, and growth/populationmodels of a small scale91,92. These
models are often focussed on the differences between normal and cancerous cells,
as well as the introduction of external factors (such as estrogen93). Their need for
system simplification is bigger than for comparablemodels of normal cells, which is
due to fewer experimental data and thus fewer available knowledge. Furthermore,
the specificity of different cancers narrows down the field of available knowledge
even more, so that most cancer modelling approaches are in direct connection to
specific experimental setups94,95 (while modellers of healthy cells have the initial
opportunity to rely on exhaustive literature searches to collect metabolite concen-
trations and kinetic parameters96). Due to these circumstances, metabolic flux
analysis (MFA) has become a convenient tool for reliably investigating details of
cancer cell metabolism97, since they do not require kinetic detail, but still yield re-
alistic impressions of metabolic flux. MFA have been applied in combination with
latest 13C isotopic tracing experiments98,99.
The final project of this thesis excels by employing a more holistic view than the
previous approaches. I perform non-stationary metabolic flux analyses for col-
orectal cancer cell lines exhibiting mutations of two common oncogenes (KRAS
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and BRAF). Furthermore, the cells are incorporatedwith 13C glucose and glutamine,
which enables us to examine details of glycolysis as well as glutaminolysis in the
cells. The results are augmented by proteomic and phosphoproteomic data, which
have been taken simultaneously to the metabolomic data. The results clearly link
the KRAS protein to the accumulation of lactic acid in cancer cells, a key feature of
the Warburg effect. Furthermore, the carbon routing through the reductive TCA
cycle could be connected to the KRAS protein as well as BRAF. These proteins are
encoded by common oncogenes that are on the one hand important players in sig-
nalling pathways and, on the other hand, known to have direct influences on can-
cer cell metabolism87. Finally, we are analysing the regulatory system on grounds
of the provided data and propose suitable experimental targets as well as appro-
priate mathematical modelling techniques to improve our results so far. With the
presented results we contribute important novelties about the details of metabolic
reprogramming in cancer cells.
The proposed results are of large interest and stand for the latest hallmark in
cancer research: metabolic reprogramming87. While more and more details on
varying enzyme concentrations in cancer cells are revealed, the causes for these
deviations from the norm are largely unknown andmostly attributed to oncogenes.
The need for the exploration of these details is evident: Cancer is one of the most
wide-spread diseases and takes second place on the list of most frequent death
causes after heart disease 100. Its nature is so heterogenous among different cancer
types and so much deviating from that of normal cells that cancer research still is a
long way from personalised treatment possibilities. Systems Biology, however, has
introduced new and favourable mathematical approaches, which, in combination
with new experimental high-throughput techniques, can accelerate the speed of
cancer research significantly95,101.
Concluding words and outlook The presented projects of my thesis comprise (i)
novel workflows for creating large-scale signalling pathway reconstructions and
kinetic metabolic models; (ii) new biological insight into the regulatory principles
of yeast and human cells; and finally (iii) a proposal for a standardised table format,
which facilitates the exchange and automated usage of data in Systems Biology.
The knowledge database which we have acquired in an extensive literature cura-
tion on the Snf1 pathway in yeast is soon going to be extended for the more recent
developments in this field of research. The database will then be the foundation of
a comprehensive review on the subject, which is a valuable compendium of manu-
ally curated knowledge on one of the most prominent pathways in yeast.
Our ongoing project on cancer cell metabolism will be refined and extended.
From the modelling side, I am currently working on the dynamic ODE model sug-
gested in the corresponding chapter. For this, I am orienting on our proposed me-
tabolic modelling framework of Chapter 2.2.2, where the results of a flux analysis
method (in this case the metabolic fluxes) are employed as input for the parameter
balancing process. Common modular rate laws are a good approximative choice
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for the reaction kinetics, where we can also easily employ the proteomic concen-
tration data as enzymatic prefactors. Furthermore, these choices of rate law and
modelling method will provide us valuable insight into the dynamics and regula-
tory principles of the system. From the experimental side, we have already taken
the MFA results as input for what can be proclaimed another round of the itera-
tive cycle of Systems Biology: Conducting new experiments. New measurements
of further observables in cancer cell metabolism are currently ongoing and might
give us even more insight into the system. And understanding a disease is a major
prerequisite of eventually curing it.
Our table format, SBtab, has already been employed by several researchers from
different parts of the world. Currently, we are near completion of an adaptation of
the SBtab format to suit the specific requirements of the rxncon software frame-
work; tailoring the SBtab format conventions to individual data formats is one of
SBtabs inherent features. The technical applicability of SBtab and its practical ben-
efits to science still need to be proven after the manuscript, which is currently un-
der revision at Bioinformatics Journal, will be published. We are still working on
improving and promoting this ongoing project and consider it a valuable addition
to Systems Biology research.
The presented workflows and projects are aimed at improving our computa-
tional modelling approaches and thus further our understanding of biological sys-
tems. As declared earlier, the benefits and implications of understanding these
systems are numerous and significant. And although the road to unravelling the
enigmas of life is still long and probably endless, I have contributed my time and
work to overcome a few of the required steps on this road.
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Appendix
4.1 SBtab specification
The specification of the SBtab format elucidates the conventions and structures of
SBtab files. Furthermore, it enlists all predefined table types for different types of
information, introduces available tools, and offers guidance for the customisation
of the SBtab format to individual data types. The specification is attached in the
most recent version 0.9, and it is publicly available on
http://arxiv.org/abs/ͤ͟͠͡.ͣͥ͟͢͠.
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Abstract
Data tables in the form of spreadsheets or delimited text files are the most utilised data format in
Systems Biology. However, they are often not sufficiently structured and lack clear naming conventions
that would be required for modelling. We propose the SBtab format as an attempt to establish an
easy-to-use table format that is both flexible and clearly structured. It comprises defined table types
for different kinds of data; syntax rules for usage of names, shortnames, and database identifiers used
for annotation; and standardised formulae for reaction stoichiometries. Predefined table types can be
used to define biochemical network models and the biochemical constants therein. The user can also
define own table types, adjusting SBtab to other types of data. Software code, tools, and further
information can be found at www.sbtab.net.
1 Introduction
Spreadsheets and delimited text tables are the most utilised data formats in Systems Biology. They are easy
to use and can hold various types of data. Tables can not only store omics data, but also metabolic network
models described by lists of biochemical reactions. However, when tables are exchanged within scientific
collaborations, modellers usually prefer tables that can be processed automatically, and the flexibility of
spreadsheets can become a disadvantage. If table structures and nomenclature vary from case to case,
parsing becomes laborious and new files require new parsers. Furthermore, different naming conventions –
for instance, for biochemical compounds – make it hard to combine data, for instance metabolic network
models and omics data produced by different researchers. Therefore, rules for structuring tables and for
consistent naming and annotations can make tables much more useful as exchange formats in Systems
Biology collaborations and for usage in software tools. The SBtab format comprises a set of conventions
for data tables that are supposed to make tables easier and safer to work with. Let us start with a couple
of examples. Then we continue with a more formal specification of SBtab version 0.9.
Example 1: Structure of a metabolic network model A stoichiometric metabolic model can be defined
by a list of biochemical reaction formulae, specifying the substrates, products, and their stoichiometric
coefficients. Such reactions can be listed in a single column of a spreadsheet, and additional information
may be provided: each reaction can have a number or identifier (defined only within the model) and can
be linked to an entry in the database KEGG Reaction [1]. Furthermore, reactions may be catalysed by
enzymes, which relates them to certain genes. All information could be stored in the following table:
Reaction Sum formula KEGG ID Gene symbol
R1 ATP + F6P <=> ADP + F16P R00658 pfk
R2 F16P + H2O <=> F6P + Pi R01015 fbp
where ATP, F6P, ADP, F16P, H2O, and Pi are shortnames for metabolites to be used in the model. Although
the information is complete and unambiguous, the parser still has to recognise that the columns Sum
formula and KEGG ID contain reaction formulae and identifiers in certain formats. If the column names
and the syntax of the reaction formulae vary from table to table (e.g. <-> is used instead of <=>), parsing
becomes tedious. In the SBtab format, the table would look a little more complicated, but is easy to parse
automatically:
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!!SBtab TableName=’Ex 1 - Reaction’ TableType=’Reaction’
!Reaction !SumFormula !Identifiers:kegg.reaction !Gene:Symbol
R1 ATP + F6P <=> ADP + F16P R00658 pfk
R2 F16P + H2O <=> F6P + Pi R01015 fbp
In this table, elements highlighted by colours have special meanings (the colours themselves are just used
in this text and are not part of the SBtab format). The SBtab table differs from the original table in several
ways: the first line (starting with !!) declares that the table is an SBtab table of the type Reaction and
must therefore satisfy syntax rules for this table type. The following line contains the column headers.
They start with the ! character, emphasising that they were not chosen ad hoc by the user, but stem from
a controlled vocabulary. The predefined column headers do not contain whitespaces. The header KEGG ID
has been replaced by the term !Identifiers:kegg.reaction. This may look complicated, but it allows
parsers to retrieve further data from databases in a stable way1. The syntax of the reaction formulae is also
uniquely defined. In particular, the shortnames of metabolites must not contain any whitespaces or special
characters, which simplifies parsing and makes them suitable as variable names for computer models. The
meaning of these shortnames can be defined by providing standardised names or database identifiers in a
second table of type Compound. The compound shortnames will then serve as keys to rows of this table.
!!SBtab TableName=’Ex 2 - Compound’ TableType=’Compound’
!Compound !Name !Identifiers:kegg.compound
F6P Fructose 6-phosphate C05345
ATP ATP C00002
ADP ADP C00008
F16P Fructose 1,6-bisphosphate C00354
H2O Water C00001
Pi Inorganic phosphate C00009
PEP Phosphoenolpyruvate C00074
AMP AMP C00020
Both tables together form an SBtab document describing a model. In practice, they can be stored as
separate files, as sheets of a spreadsheet file, or within a single table. The following example contains all
necessary information to build a stoichiometric model in the SBML (Systems Biology Markup Language)
format [3]:
!!SBtab TableName=’Ex 3 - Reaction’ TableType=’Reaction’
!Reaction !SumFormula !Identifiers:kegg.reaction !SBML:reaction:id
R1 ATP + F6P <=> ADP + F16P R00658 r1
R2 F16P + H2O <=> F6P + Pi R01015 r2
!!SBtab TableName=’Ex 3 - Compound’ TableType=’Compound’
!Compound !Name !Identifiers:kegg.compound !SBML:species:id
F6P Fructose 6-phosphate C05345 f6p
ATP ATP C00002 atp
ADP ADP C00008 adp
... ... ... ...
Here, we have added new identifiers (in the columns SBML:reaction:id and SBML:species:id) for
Reaction and Compound entries to be used in SBML. Such extra names could be necessary if the original
shortnames do not comply with SBML’s rules for element identifiers.
Example 2: Table of kinetic constants In a second example, we specify numerical parameters, for
example kinetic constants and metabolite concentrations that appear in a kinetic model. Each quantity
can be related to a compound (e.g. a concentration), to a reaction (e.g. an equilibrium constant), or to
several biological elements (e.g. to an enzyme and a compound, in the case of Michaelis-Menten constants).
As in the previous example, these elements can be specified by unique identifiers, e.g. KEGG compound or
reaction identifiers. Furthermore, each quantity has a value and a physical unit. In the SBtab format, we
arrange this information in a table of type Quantity. Each row contains all information about one of the
quantities:
1The expression kegg.reaction is defined by the MIRIAM resources and used within SBtab. The URL of the KEGG
database, defining the identifiers, may change in the future; however, KEGG’s Miriam ID (provided by the the MIRIAM
resources web service [2]) is guaranteed to remain stable in time.
2
!!SBtab TableName=’Ex 4 - Quantity’ TableType=’Quantity’
!Quantity !QuantityType !Reaction:Identifiers:kegg.reaction !Compound:Identifiers:kegg.compound !Value !Unit
keq R1 equilibrium constant R01061 0.156 dimensionless
kmc R1 C1 Michaelis constant R01061 C00003 0.96 mM
kic R1 C1 inhibition constant R01070 C00111 0.13 mM
con C1 concentration C00118 0.203 mM
... ... ... ... ... ...
The first two columns specify a name and a type for each quantity. The quantity types (substrate
catalytic rate constant, equilibrium constant etc.) are not chosen ad hoc, but stem from the
Systems Biology Ontology (SBO) [4]. This ensures a unique spelling and allows software to retrieve
definitions and further information from the SBO web services. The biological elements (in this case,
reactions, compounds, or both) are specified in the following two columns by unique identifiers from the
KEGG database. Columns with human-readable names, or identifiers from other databases, could be
added. Unnecessary fields remain empty. The column name Value – like some other mathematical terms
– is defined for SBtab (arbitrary values in this example). Unit names are defined as in SBML (see below).
If the table is used together with a metabolic model, we can use compound and reaction identifiers from
the model instead of the Identifiers.org annotations [5]. In this case, the table would read:
!!SBtab TableName=’Ex 5 - MyData’ TableType=’Quantity’
!Quantity !QuantityType !SBML:reaction:id !SBML:species:id !Value !Unit
MyData 1 equilibrium constant r1 0.156 dimensionless
MyData 2 Michaelis constant r1 atp 0.96 mM
MyData 3 inhibition constant r1 atp 0.13 mM
MyData 4 concentration atp 1.5 mM
... ... ... ... ... ...
This table, together with a stoichiometric model and a choice of standardised rate laws (like the modular
rate laws [6]) completely defines a kinetic metabolic model.
Example 3: A table with metabolome data As a last example, let us consider a table with metabolome
time series data. For the sake of simplicity, only two metabolites (rows) and measured samples (columns)
are shown:
!!SBtab TableType=’QuantityMatrix’ TableName=’Ex 6 - Metabolomics data’ UniqueKey=’False’
!Compound !Identifiers:obo.chebi t = 0 s t = 0.5 s ..
Glucose CHEBI:17234 1.1 1.2 ..
Fructose CHEBI:15824 1.4 0.9 ..
.. .. .. .. ..
Tables of this sort can be also be used for other kinds of omics data. In this example, the headers of
data columns (e.g., t = 0 s) do not follow a specific syntax and contain relevant information (time point
and time unit). We shall see below how such information can be provided in SBtab in a more structured
manner.
In the following sections, we introduce the general SBtab rules (specification for SBtab version 0.9), as well
as formats and conventions for different types of use (see Section 2). It defines a list of table types (see
Section 3) and explains the syntax of reaction formulae in the SBtab format (see Section 2.5). Finally, the
specification references the available online tools for the handling of SBtab files (see Section 5) and includes
an overview of all available SBtab table types in appendix B. Appendix C lists controlled vocabularies and
database resources recommended to be used within SBtab.
2 Overview of the SBtab format
2.1 Basic conventions
SBtab comprises a list of conventions about the structure, nomenclature, syntax, and annotations in tables
describing biochemical network models, kinetic parameters, and dynamic data. It contains
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1. General rules for the structure of tables and the syntax used in table fields.
2. Defined table types for different kinds of information, each with possible columns with defined
names and data types (see Table 1; An overview of all predefined table types and their possible
columns is given in the appendix).
3. A syntax for biochemical element annotations pointing to databases or ontologies.
4. Rules for usage of names, shortnames, and database identifiers used for annotation.
5. Naming rules for biochemical quantities to specify the quantities, physical units, and mathematical
terms (like Mean for mean values).
6. A syntax for reaction sum formulae.
7. A mechanism for extending the format by declaring new column or table types.
While the general rules apply to all kinds of data, the current version of SBtab is tailored for describing
the structure of biochemical network models and the biochemical quantities therein. This is reflected by
the table types defined in Table 1.
Colour highlighting and predefined terms In the examples shown in this text, predefined SBtab entries
are highlighted in colours. This is just for convenience and is not a part of the SBtab format. Table
types and Column types defined by the SBtab format are listed in Table 1. Shortnames can be chosen
ad hoc by the user; each of them needs to be defined by a table row. Shortnames have to be unique
and consistent within a document, but may differ between documents. Reserved names are predefined in
SBtab for recurrent mathematical expressions like “mean value”. Official names, like the names used
for databases, are defined by some other authority. Free text and other text including database IDs,
numerical values, mathematical brackets, and operators is written in black.
2.2 SBtab tables and SBtab documents
General table structure An SBtab document consists of one or several tables that refer to a common
model or related data sets. All tables must use a common list of shortnames. For instance, a Compound
table contains the column !Compound, and the elements from this column define compound shortnames to
be used in the other tables. Several tables in a document may have the same type, but their table names
(attribute TableName) must be unique.
Declaration row containing the table attributesThe top left field contains the table header, starting with
!!SBtab and followed by the table attributes in the syntax attribute name=´attribute value´, separated
by whitespaces. Mandatory attributes are TableType and TableName.
Column headers and definition table The second row contains the column headers. Columns whose
headers start with a ! are treated as SBtab columns and must adhere to the SBtab rules. Other columns
can contain arbitrary content. SBtab has a number of predefined table types that can hold different kinds
of data. Each table type has a number of mandatory or optional columns with specific properties. An
overview is given below and in the appendix. However, users can also define their own table types and
corresponding columns. This definition must be provided by the user in the form of a special Definition
table (as described below).
Column with unique keys By default, any SBtab table must start with a column matching its table type
(e.g., a table of type Quantity must start with a column Quantity) and containing shortnames that serve
as unique identifiers for the table elements. If a table does not have such a column with unique key, this
should be marked by setting the attribute UniqueKey=’False’ in the declaration row of the table. The
attribute is set to True by default.
Completeness To interpret the contents of a single table, other tables (e.g. describing shortnames) may
be required. If a table does not require any other tables, we call it “complete”. A document is complete if
all names are defined, i.e. no unspecified information is required to interpret its contents. If a single table
or a document are incomplete, the undefined names have to be known by the software, and an exchange
with other software tools is likely to fail. If a table or document contains two elements, and there is no
explicit information implying that they describe the same things, it is assumed that they describe different
things.
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Name Contents Usage
Compound Names, IDs, properties of compounds model structure
Enzyme Names, properties of enzymes model structure
Protein Names, properties of proteins model structure
Gene Names, properties of genes model structure
Regulator Names, properties of gene regulators model structure
Compartment Names and IDs of compartments model structure
Reaction Chemical reactions model structure
Quantity Individual data for model parameters quantitative data
QuantityMatrix Data matrices quantitative data
Relation Relations between different compounds model structure
Definition Define custom column types, etc. customise SBtab
Table 1: Overview of table types predefined in SBtab.
Conventions for spreadsheet files To ensure consistency between spreadsheet files, we propose a number
of rules for good practice:
• UTF8 encoding If possible, the UTF8 encoding should be chosen.
• Documents In character-separated text files (.csv or .tsv), a document can either be stored in several
files with the filenames basename tablename.extension, or tables are concatenated vertically, each
preceded by a declaration row (starting with !!), and stored in a single table file.
• Delimiters in .csv or .tsv files In character-separated files, irrespective of the extension (.csv or
.tsv), it is assumed by default that the delimiters are tabulators. However, other delimiters (comma
or semicolon) are accepted by the parser as well.
• Special characters If table cells contain special characters that are also used as cell delimiters
(e.g. commas), the file must be provided in a form that excludes ambiguities (e.g. in the case of a
comma-separated table containing commas with its fields, all cells must additionally be marked by
quotation marks ("..").
Filenames The SBtab format as such does not impose any restrictions on filenames, nor does it require
a specific filename extension. SBtab files stored as excel sheets, for instance, will have the extension
.xls. However, the SBtab online tools (and the python programs behind it) have a certain convention for
filenames and filename extensions. When an SBtab document is exported to several delimited text files,
the filenames will be chosen according to the scheme [SBTAB DOCUMENT NAME] [TABLE TYPE].csv or,
in case of ambiguities [SBTAB DOCUMENT NAME] [TABLE TYPE] [TABLE NAME].csv.
Filename extensions Regarding filename extensions, the python implementation of SBtab supports comma-
separated and tab-separated tables, as well as excel spreadsheet files (xls). By default, the python code
exports tab-separated files and uses the filename extension .csv. This is a convention supported by Li-
breOffice, but may lead to conflicts in other cases. Some tools require extensions like .tab (excel) or
.tsv (e.g., the formatting option in github). We do not use .tsv in this case, because this is supported
neither by excel nor by LibreOffice. In case of conflicts, users may have to simply rename their files. When
importing a table, the code tries to determine whether commas or tabs are used as delimiters. When using
commas as delimiters, users have to make sure that no commas are used elsewhere in the table (or that
all elements are given in double quotes).
2.3 Names of biochemical elements
Names and identifiers of model elements In the following, compounds, enzymes, genes, genetic reg-
ulators, and compartments will be called “biochemical entities”. “Biochemical elements” comprises, in
addition, reactions and biochemical quantities. Biochemical elements can be described by shortnames, of-
ficial names, or database identifiers (IDs). The shortnames have to be declared within the SBtab document
and have to satisfy syntactic rules. Each table starts with a column of the same name, containing the short-
names. Shortnames, the arbitrary element names used in a data set or model, must be unique, i.e. declared
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only once in a document; they must start with a letter and may not contain spaces or the special characters
“:”, “.”. In columns containing database IDs, the column name (!Identifiers:Identifiers) specifies the
database by a name (to be used in column names, IDs etc.) and an URI. We suggest to use preferably the
databases listed in the Miriam file (see Table 16). Sometimes, elements may be characterised redundantly:
e.g. the reaction catalysed by an enzyme, given in an Enzyme table, can be given by both shortname and
database ID. In case of conflict, the information derived from the shortname (i.e. the database ID listed in
the Reaction table) has higher priority.
Naming and specification of biological entities Tables of the types Compound, Enzyme, Gene, Regulator,
or Compartment are called “entity tables”. The biochemical meaning of the entities can be declared by
different columns:
• !Name contains official names (it is good practice to use names from the suggested databases).
Several names can be listed in one field, separated by “|”. To declare from which database a name
has been taken, the name can also be written as DB:name.
• !Identifiers:Identifiers contains IDs from a specified database. Annotations with database IDs
follow the scheme defined by Identifiers.org [5] (data collection and ID).
Localised compounds If a compound, enzyme, or genetic regulator is localised in a compartment, the
corresponding localised entity can be denoted by compound[compartment] with square brackets, where
compound and compartment are the shortnames or IDs of the compound and the compartment used in
the model. If a model contains several compartments, tools should treat the first compartment in the
Compartment table as the standard compartment. The standard compartment will be used by default for
all compounds that are not explicitly assigned to compartments.
2.4 Annotating biochemical elements with database identifiers
Biochemical elements are annotated with database IDs listed in special identifier columns. An Identifiers
column contains annotations from one web resource, at most one annotation per element, and without
qualifiers. The column item and the referenced ID are assumed to be linked by an “is” relationship (and not,
for instance, “version of”, which can exist in SBML annotations). A table can contain several Identifiers
columns, which must refer to different data resources.
!!SBtab TableName=’Ex 7 - Compound’ TableType=’Compound’
!Compound !Identifiers:obo.chebi !Identifiers:kegg.compound ...
water CHEBI:15377 C00001 ...
ATP CHEBI:15422 C00002 ...
phosphate CHEBI:18367 ...
To translate an element like CHEBI:16865 into a valid Identifiers.org URI, http://identifiers.org/ is
concatenated with the data collection mentioned after !Identifiers: in the header (e.g. obo.chebi)
and with the column item, separated by a slash2. For instance, the first annotation entry in the table above
would be resolved to http://identifiers.org/obo.chebi/CHEBI:15377.
2.5 Syntax for reaction formulae
Chemical reactions can be described by reaction formulae (column !SumFormula in table Reaction;
specifying the reactants, their stoichiometric coefficients, and possibly their localisation). The reaction
arrow is denoted by <=>. Stoichiometric coefficients refer to substance amounts, not concentrations
(this matters in the case of transport reactions). Stoichiometric coefficients of 1 are omitted; general
stoichiometric coefficients, given by letters (e.g. n) are not allowed. If possible, the reaction formula should
represent the actual stoichiometries experienced by the enzyme (i.e. A <=> 2 B rather than 0.5 A <=>
B). Substrates and products are given by shortnames, which must be defined in a Compound table. The
2The elements from the column have to be translated into a URN-encoded form (as described in the URN specifica-
tion): for instance, the colon in the identifier CHEBI:16865 has to be replaced by the string “%3A” to create the URN
obo.chebi:CHEBI%3A16865.
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order of substrates and the order of products are arbitrary; however, comparison of formulae is eased by
using an alphabetical order. The localisation in compartments can be denoted as follows:
• Reaction in the default compartment: A + 2 B <=> C + D
• Transport reaction: A[comp1] + 2 B[comp1] <=> C[comp2] + D[comp2]
In the example, A, B, C, and D are compound shortnames, and comp1 and comp2 are compartment
shortnames. The reversibility of reactions is not given by the sum formula, but by an extra column
!IsReversible in the Reaction table.
3 Overview of predefined table types
SBtab predefines a number of table types with specific properties. An overview is given in Table 1. The table
types Compound, Enzyme, Gene, Regulator, Compartment, and Reaction describe model structures, the
table types Quantity, QuantityMatrix, and Relation are used for quantitative data.
3.1 Tables for biochemical network structures
As in example 1 (in the introduction section), biochemical networks consist of biochemical entities (e.g. metabo-
lites or proteins) and reactions or interactions between them. The tables describing these entities (table
types Reaction, Compound, Compartment, Enzyme, Regulator, and Gene) have to satisfy the following
rules.
• Entities In tables describing biochemical entities (Compound, Enzyme, Gene, Regulator, Compartment),
each row has to contain (i) a shortname as the primary key (in the column !Compound, !Enzyme,
etc.) and (ii) at least one entry specifying the entity, like !Name or !Identifiers:DB. If a column
shares the type of the table (e.g. a Compound column in a Compound table), it can be considered
a primary key, that is, its elements should be unique and it should appear as the first column in the
table. Optional columns - which may depend on the kinds of entities - are listed in Table B.2.
• Reactions A Reaction table lists chemical reactions, possibly with information about the corre-
sponding enzymes, their kinetic laws, and their genetic regulation. It must contain at least one of
the following columns: !SumFormula, !Identifiers:DB; optional columns are listed in Table 11.
For an example, see example 1 in the introduction.
• Enzymes, genes, and regulators The connection between chemical reactions, the enzymes catalysing
the reactions, and the genes coding for the enzymes can be complicated, but in many cases, there is
a one-to-one relationship. In SBtab, there are different ways to express this relationship. Information
about enzymes or genes and their regulation can be stored in a Reaction table if there is a one-to-
one relationship between reactions, enzymes, and possibly genes. Otherwise, it is stored in separate
tables Enzyme and Gene and the tables are interlinked via the columns !Enzyme (in table Reaction)
and !Gene (in table Enzyme) or !TargetReaction (in an Enzyme table) and !GeneProduct (in a
Gene table).
3.2 Table type Quantity for biochemical parameters
Numerical data (e.g. for time series or kinetic parameters) can be stored in tables and be linked to model
elements via the latters’ shortnames. There are two different table types for numerical data. Tables of
type Quantity describe individual physical or biochemical quantities, for instance, kinetic parameters in a
network model. These quantities can be linked to one entity, one reaction or enzyme, or both. If a quantity
table contains several values for the same quantity, they appear in separate rows (for possible descriptions
of provenance, see Table 10).
Tables of type Quantity describe single physical or biochemical quantities (e.g. individual kinetic con-
stants). A quantity is defined by a type, a unit, possibly biochemical entities to which it refers, possibly a
localisation, and possibly experimental or physical conditions. The columns contain the defining properties
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(e.g. unit, conditions, etc.) and their values. Quantities can refer to a compound, an enzyme or reaction,
or a combination of them. For instance, a concentration refers to a substance, while a kM value refers
to a metabolite and an enzyme. If there is a one-to-one relationship between reactions and enzymes, the
k
M value can also be assigned to a compound/reaction pair or a compound/enzyme pair. Let us consider
again example 2:
!!SBtab TableName=’Ex 8 - Quantity’ TableType=’Quantity’
!Quantity !QuantityType !Reaction:Identifiers:kegg.reaction !Compound:Identifiers:kegg.compound !Value !Unit
keq R1 equilibrium constant R01061 0.0984 dimensionless
kmc R1 C1 Michaelis constant R01061 C00003 0.96 mM
kic R1 C1 inhibition constant R01070 C00111 0.13 mM
con C1 concentration C00118 0.203 mM
To specify the parameters of a model, we refer to Reaction and Compound elements by shortnames rather
than by resource IDs. In this form, the above example becomes
!!SBtab TableName=’Ex 9 - Quantity’ TableType=’Quantity’
!Quantity !SBO:Identifiers:obo.sbo !Reaction !Compound !Value !Unit
kcrf R1 SBO:0000320 R1 200.0 1/s
keq R1 SBO:0000281 R1 0.0984 dimensionless
kmc R1 C1 SBO:0000027 R1 C1 0.96 mM
kic R1 C2 SBO:0000261 R1 C2 0.13 mM
con C3 SBO:0000196 C3 0.203 mM
This example shows that quantity types can be specified by identifiers from the Systems Biology Ontology
(SBO) in a column !SBO:Identifiers:obo.sbo.
A Quantity table can also store state-dependent quantities like concentrations, expression levels, or fluxes,
like in the following example.
!!SBtab TableName=’Ex 12 - Quantity’ TableType=’Quantity’
!Quantity !Compound !Condition !SBO:concentration !Unit
con C1 wt C1 wildtype 0.2 mM
con C2 wt C2 wildtype 1 mM
con C3 wt C3 wildtype 0.1 mM
con C1 mu C1 mutant 0.1 mM
con C2 mu C2 mutant 0.5 mM
con C3 mu C3 mutant 0.1 mM
3.3 Table type QuantityMatrix for data matrices
Biological data often have the form of matrices. As an example, consider a small 2×2 matrix containing
metabolite concentrations for two time points and two metabolites. It can be expressed by the following
SBtab table.
!!SBtab TableType=’QuantityMatrix’ TableName=’Ex 13 - Metabolomics data’ UniqueKey=’False’
!Time Glucose Fructose
0.0 1.1 1.4
0.5 1.2 0.9
The headers of the data columns are not defined headers starting with “!”, but simple strings. Therefore,
they are not formally controlled by SBtab. Annotating these columns, e.g., by adding ChEBI Identifiers to
specify the metabolites, is not directly possible. Moreover, the time points have no keys to which other
tables could refer. An alternative solution looks as follows:
!!SBtab TableType=’QuantityMatrix’ TableName=’Ex 14 - Metabolomics data’ UniqueKey=’False’
!TimePoint !Time >Measurement:Glucose >Measurement:Fructose
T0 0.0 1.1 1.4
T1 0.5 1.2 0.9
Here, the column headers are controlled and point to rows of another table with table name “Measurement”,
in which the ChEBI Identifers are given:
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!!SBtab TableType=’Quantity’ TableName=’Ex 15 - Measurement’ UniqueKey=’False’
!Compound !Identifiers:obo.chebi !QuantityType !Unit
Glucose CHEBI:17234 concentration mM
Fructose CHEBI:15824 concentration mM
Now let us consider data tables in which time points are represented by columns. A similar scheme can be
used in this case. The first, simple version would read:
!!SBtab TableType=’QuantityMatrix’ TableName=’Ex 16 - Metabolomics data’ UniqueKey=’False’
!Compound !Identifiers:obo.chebi t = 0 s t = 0.5 s
Glucose CHEBI:17234 1.1 1.2
Fructose CHEBI:15824 1.4 0.9
Here, it would obviously be good to store time point and time unit separately instead of merging them in
the column header. This can be realised as follows:
!!SBtab TableType=’QuantityMatrix’ TableName=’Ex 17 - Metabolomics data’ UniqueKey=’False’
!Compound !Identifiers:obo.chebi >TimePoint:t0 >TimePoint:t1
Glucose CHEBI:17234 1.1 1.2
Fructose CHEBI:15824 1.4 0.9
with an extra table
!!SBtab TableType=’Quantity’ TableName=’Ex 18 - TimePoint’ UniqueKey=’False’
!TimePoint !Time !Unit
t0 0 s
t1 0.5 s
3.4 The table type Relation for pairwise relations
The table type Relation is used to define pairwise links between objects. Each link (“relationship”) can
have a type and a numerical value. A Relation table can, for instance, be used to define a directed graph
(by listing the edges between nodes of one type) or a gene regulatory network (by listing the actions of
transcription factors on gene promoters). In particular, Relation tables can be used to link SBtab elements
between tables and, thus, to create SBtab documents that have the form of a relational database.
!!SBtab TableName=’Ex 19 - LittleGraph’ TableType=’Relation’ UniqueKey=’False’
!From !To !Relation !Value
A A regulates 1
A B regulates -1
B A regulates 1
B C regulates 2
C D regulates 1
3.5 Table type Definition for customising the SBtab format
Users can define their own table types and corresponding columns. For usage in the online tools or in the
python code, this definition can be provided by the user in the form of a special Definition table. The
default table (containing the predefined table and column types) is available on the SBtab website. Note
that, when using a new Definition table, the predefined Definition table will be completely overridden, so
any tables and columns to be used (also the predefined ones) must be listed in the new table. The typical
format of a Definition table is shown below.
!!SBtab TableType=’Definition’ TableName=’Ex 20 - Def’
!Component !ComponentType !IsPartOf !Format !Description
SBML:reaction:id Column Reaction String SBML ID of reaction
SumFormula Column Reaction String Reaction sum formula
Enzyme Column Reaction String Enzyme catalysing the reaction
... ... ... ... ..
The Format column defines which type of entries a column can contain. Possibilities are String,
Shortname (name of SBtab element, as defined in one of the SBtab tables), Number (integer or float
9
in usual formats, or complex numbers like 1 + i 3), or Boolean (with possible values True and False,
or alternatively 1 and 0). More specific string formats (e.g., for reaction sum formulae) are currently not
formally defined, but can be mentioned in the Description column.
4 Conversion between SBtab and SBML
SBML (Systems Biology Markup Language) models can be converted into SBtab documents and vice
versa. Depending on the content of the SBML model, the SBtab files can comprise table types Reaction,
Compound, Compartment, Quantity, Events, and Rules. Likewise, these SBtab table types can be
converted into an SBML (Level 2, Version 4) model. The conversion to SBML, however, requires at least
either a Reaction or Compound SBtab.
The conversion from an SBML model file to SBtab translates the structural and temporal information of
the model into corresponding SBtab table files. The (i) Reaction SBtab contains a list of the reactions of
the SBML file, including their sum formula, kinetic laws, irreversibility, annotations, and more. Note that
the SBML modifiers of a reaction (e.g. enzymes) cannot be identified as inhibitor or stimulator if they are
not assigned an SBO Term within the SBML code. If this is not the case, they will only be exported to
SBtab as modifiers without regulatory information. All species from the model can be found in the (ii)
Compound SBtab. Their location, charge, annotations, and more are provided in the SBtab. Analogously, a
(iii) Compartment holds all structural information of the cellular compartments. The (iv) Quantity SBtab
file lists all parameters that are part of the model. Also their numerical values and units will be provided.
The parameters can appear as either local or global variables in the SBML code; this information will be
transferred to SBtab as well. (v) Events can be an important part of SBML models; they indicate e.g.
concentration changes or stress applications at certain time points. They too are translated into an SBtab
file. Finally, (vi) rules are exported from SBML to an SBtab Rule table. Rules can comprise assignment
rules, algebraic rules, and rate rules. Rule formulas and units are part of the conversion as well.
In the conversion from SBtab to SBML, Compound entries in SBtab correspond to species elements in
SBML. By default, the unique keys in the Compound and Reaction SBtab are used as id attributes of the
SBML elements. If SBML IDs are directly specified within SBtab (in the columns SBML:reaction:id,
SBML:species:id, SBML:parameter:id, SBML:reaction:parameter:id, etc), these will be used in-
stead. Rate laws from the SBML code are stored in SBtab as strings within a KineticLaw column. Note
that the rate laws are not checked for their validity. It is up to the user to assure the correctness of
the rate laws. If they are erroneous, this leads to invalid SBML output. An automatic parser of rate
laws including checks of validity is planned for future versions of SBtab. Regulator entries in SBtab
correspond to modifier elements in SBML; multiple regulators can be described by a regulation formula
(in the Regulator column): regulators are separated by a “|” symbol, while the sign of regulation can
be denoted by + or -. For an enzyme allosterically inhibited by ATP and activated by ADP, the formula
reads -ATP|+Pyruvate or ATP|ADP where inhibition and activition remain unspecified. Also rate rules
and assignment rules can be converted from SBtab to SBML. Note that, just like for kinetic rate laws,
these rules do not underlie constraints of validity. It is up to the user to ensure their correctness before
conversion to SBML. Finally, SBtab is able to provide lists of events for the SBML file. This includes the
event assignments, triggers, delays, and more. For all aforementioned SBML elements, annotations are
automatically translated from the SBtab to the SBML file, if they adhere to the correct syntax.
The entries of Quantity tables can be inserted into SBML models or be extracted from them. By
default, SBtab quantities referring to a reaction will become local reaction parameters in SBML, while
other quantities become global parameters. The element of the !Quantity column will be used as SBML
element ID unless it is overridden by the (optional) column !SBML:parameter:id (for global parameters)
or !SBML:reaction:parameter:id (for local reaction parameters). Naming conventions for kinetic
constants are given in [6], supplementary material Table A.5. Quantities that describe initial species
amounts, initial species concentrations, or compartment sizes will be translated into the corresponding
SBML element attributes.
There are still limitations to the conversion of SBtab and SBML. So far, the conversion does not include
element notes and function definitions. These issues are planned to be solved in future versions of SBtab.
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5 SBtab tools
To simplify the usage of SBtab, we provide several online tools at www.sbtab.net.
1. Online validator for SBtab files. The online validator
tool checks whether SBtab files (in .csv or .xls format) adhere
to the SBtab conventions introduced in this manuscript. If a
problem is identified by the validator, an instruction on how
to fix the problem is provided. The validation is based on the
SBtab table definitions found in the Definition table.
2. Online SBtab↔ SBML converter The online conversion
tool can create SBtab files from SBML models and vice versa.
For the conversion from SBtab to SBML, it has to be assured
that at least an SBtab table of type Reaction or Compound is
provided. As additional information, the following SBtab table
types can be used for the conversion to SBML:Compartment,
Quantity, Events, and Rules. All information comprised in
these SBtab tables can be converted to the SBML structure,
as long as they are adhering to the correct syntax. Therefore,
it is recommended to validate the SBtab files with the online
validator before recruiting them for a conversion to SBML.
The generated SBtab files can be displayed online as HTML
tables. If annotations are correctly provided, they will link to
the web resource. For the conversion it is recommended to
use SBML Level 2, Version 4, or higher. The details on the
conversions can be read in Chapter 4.
3. MS Excel Add-in The described validator and converter
functions can also be attained with an add-in for Microsoft
Excel. It can be retrieved from the SBtab Github Repository
and installed with a Windows Installer Package. The prereq-
uisites for the installation of the add-in are (i) Windows Vista
or higher, (ii) Microsoft Office 2010 or higher, (iii) Microsoft
.NET Framework 4.5 (full) or higher, and Microsoft Visual
Studio 2010 Tools for Office Runtime (VSTO). The latter
two can be downloaded directly from Microsoft.
Python parser for SBtab files. In addition, we provide a SBtab parser written in Python. It uses the
Python package tablib to import SBtab files and provides different functions for editing the data and
for directly accessing them. These features are important for the embedding of the SBtab file parser into
software projects. The common operations for manipulating SBtab files contain:
1. Extracting characteristic table information (type, name, etc.).
2. Addition of rows and columns to the SBtab table.
3. Editing and export of the table content in rows, columns, and single entries. An export as a Python
dictionary is also possible, to ensure easy access to the data for python programmers.
4. Switching of columns and rows in the table (matrix transposition). As some data are stored conve-
niently in transposed spreadsheets, some tables need to be transposed to have better access to its
content.
5. Duplicate SBtab objects.
6. Writing SBtab files to the hard disk.
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A Summary of SBtab rules
We summarise the most important conventions implemented by SBtab:
• Shortnames Model elements (e.g. compounds) are referred to by shortnames, which are defined in
the corresponding table (e.g. Compound for compounds) . Shortnames must be unique within an
SBtab document. The first column of each table shares the name of the table type (e.g. column
!Compound in table type Compound) and contains the shortnames, which serve as primary keys for
this table and must therefore be unique. If a table does not contain such a unique key column, this
must be declared by setting the table attribute UniqueKey=’False’ (this can be the case for tables
of type QuantityMatrix, for instance).
• Order of columns The allowed column types depend on the table type, but their order is arbitrary.
The only exception is the first column, which contains the shortnames (acting as keys for this table)
and whose name corresponds to the table type. However, it is good practice to sort the columns by
importance and to arrange related columns next to each other (e.g. placing a column Value next to
a column Unit).
• ASCII Characters The table fields contain only plain text. The format is case-sensitive, but the
choice of fonts (bold, italic) does not play a role. Double quotes should not be used.
• Decimal points To simplify parsing, we recommend to use decimal points (instead of decimal
commas).
• Table types and column names Table types and their possible columns are defined in appendix B.
Column names may not contain any special characters or white spaces (parsers should ignore these
characters).
• Comment lines Table lines starting with a “%” character contain comments and are ignored during
parsing.
• Comments and references Additional information about table elements can be stored in the optional
columns !Comment, !Reference, !Reference:Identifiers:pubmed, and !ReferenceDOI, which
can appear in all tables.
• Unrecognised table or columns Columns with unknown headers (not starting with !), or unrecog-
nised header starting with ! may appear in SBtab tables. They can be used, but are not supported
by the parser. The use of undefined columns is inadviseable.
• Declaration line The first line, starting with !!SBtabmust declare at least the attributes: TableType,
TableName, and possibly the properties SBtabVersion (for SBtab version used) and Document. The
entries can be separated by whitespaces or be given in separate fields of the declaration line.
• Identifiers Identifiers for compounds, compartments etc. can be specified in columns with a header
“ElementType:Identifiers:DB”).
• Missing elements If an element is missing, the table field is left empty. Missing numerical values
can also be indicated by non-numerical elements like ? or na (for “not available”). Mandatory fields
must not be empty.
• Formulae Reaction sum formulae must be written in a special format explained below.
• Reserved names In the SBtab format, there are reserved names for (i) table types (marked by
colours in this text); (ii) column names; (iii) types of biological elements (see Table 17); and (iv)
types of biochemical quantities or mathematical terms (e.g. Mean) for them (see Table 18), and
physical units.
• Physical units In SBtab, it is recommended to use the units listed in the SBML specification (see
sbml.org/Documents/Specifications)3. As good practice, derived units (e.g. kJ/mol) and reciprocal
units (e.g. 1/s) should be given in the simplest possible form, in necessary using multiplication,
division, exponentials, and round brackets (e.g. gram/m^3).
3The following units are supported by SBML: ampere, gram, katal, metre, second, watt, becquerel, gray,
kelvin, mole, siemens, weber, candela, henry, kilogram, newton, sievert, coulomb, hertz, Litre, ohm,
steradian, dimensionless, item, lumen, pascal, tesla, farad, joule, Lux, radian. Orders of magnitude can
be denoted by k, M, c, m, mu, n, p, f for Kilo, Mega, Centi, Milli, Micro, Nano, Pico, Femto. If a parameter is
dimensionless, it has to be annotated as dimensionless.
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B Overview of table types
B.1 Document and table attributes and general column types
Table attributes
Name Type Format Mandatory Content
TableType text string X Table type (as defined in definition table)
TableName text string X Table name
SBtabVersion text string SBtab version number
Document text string SBtab document name
UniqueKey text Boolean Requirement of a unique key identifier
ReferenceDescription text string Name of reference description
Document text string Document name
ReferenceCitation text string Citation, unique identifier, unambiguous URL
ModelCreators text string Name and contact information for model creators
ModelCreationTime text string Date and time of model creation and last modification
TermsOfDistribution text string Terms of distribution
Table 2: Possible table attributes (to appear in declaration row). The attributes in the lower part would
be necessary for MIRIAM compliance. If ReferenceCitation contains a pubmed Id, the attribute
ReferenceCitation:Identifiers:pubmed should be used instead. ReferenceCitation should also
identify the authors of the model.
All table types
Name Type Format Content
!Description text string Description of the row element
!Comment text string Comment
!ReferenceName text string Reference title, authors, etc. (as free text)
!Reference:Identifiers:pubmed text string Reference PubMed ID
!ReferenceDOI text string Reference DOI
Table 3: Columns that can appear in all tables
All entity and reaction tables
Name Type Format Content
!Name text string Entity name
!Identifiers:DataCollection resource ID string Entity ID
!MiriamAnnotations annotation string Entity ID (JSON string)
!Type text string Biochemical type of entity (examples see Table 17)
!Symbol text string Short symbol (e.g., gene symbol)
!PositionX number float x coordinate for graphical display
!PositionY number float y coordinate for graphical display
Table 4: Columns that can appear in all entity (i.e. Compound, Enzyme, Gene, Regulator, and
Compartment) and Reaction tables.
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B.2 Predefined table types
Compound
Name Type Format Content
!Compound shortname string Compound shortname
!SBML:species:id SBML element ID string SBML Species ID of the entity
!SBML:speciestype:id SBML element ID string SBML SpeciesType ID of the entity
!InitialValue number float Initial amount or concentration
!Unit string string Unit for initial value
!Location shortname string Compartment for localised entities
!State shortname string State of the entity
!CompoundSumFormula text string Chemical sum formula
!StructureFormula text string Chemical structure formula
!Charge number integer Electrical charge number
!Mass number float Molecular mass
!Unit text string Physical unit
!IsConstant Boolean Boolean Substance with fixed concentrations
!EnzymeRole shortname string Enzymatic activity
!RegulatorRole shortname string Regulatory activity
Table 5: Columns that can appear in Compound tables
Enzyme
Name Type Format Content
!Enzyme shortname string Enzyme shortname
!CatalysedReaction shortname string Catalysed reaction
!KineticLaw:Name name string Rate law (name as in SBO)
!KineticLaw:Identifiers.obo.sbo shortname string Rate law SBO identifier
!Pathway text string Pathway name (free text)
!Gene shortname string Gene coding for enzyme (shortname)
!Gene:Name string string Gene coding for enzyme (name)
!Gene:Symbol string string Gene coding for enzyme (short symbol)
Table 6: Columns that can appear in Enzyme tables
Protein
Name Type Format Content
!Protein shortname string Protein shortname
!Name text string Protein name
!Symbol string string Protein symbol
!Gene shortname string Gene shortname
!Gene:Name text string Gene name
!Gene:Symbol string string Gene symbol
!Gene:LocusName string string Gene locus name
!Mass number number Protein mass
!Size number number Protein size
Table 7: Columns that can appear in Protein tables
Gene
Name Type Format Content
!Gene shortname string Gene shortname
!Name text string Gene name
!Symbol string string Gene symbol
!LocusName string string Gene locus name
!GeneProduct shortname string Gene product shortname
!GeneProduct:Name string string Gene product name
!GeneProduct:Symbol string string Gene product symbol
!GeneProduct:SBML:species:id SBML element ID string SBML ID of protein
!Operon shortname string Operon in which gene is located
Table 8: Columns that can appear in Gene tables
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Regulator
Name Type Format Content
!Regulator shortname string Regulator shortname
!State shortname string State of the regulator
!TargetGene shortname string Target gene
!TargetOperon shortname string Target operon
!TargetPromoter shortname string Target promoter
Table 9: Columns that can appear in Regulator tables
Compartment
Name Type Format Content
!Compartment shortname string Compartment shortname
!Identifiers:obo.sbo shortname string Compartment SBO term
!SBML:compartment:id SBML element ID string SBML Compartment ID
!OuterCompartment shortname string Surrounding compartment (short)
!OuterCompartment:Name string string Surrounding compartment (name)
!OuterCompartment:SBML:compartment:id SBML element ID string Surrounding compartment
!Size number float Compartment size
!Unit text string Physical unit
Table 10: Columns that can appear in Compartment tables
Reaction
Name Type Format Content
!Reaction shortname string Reaction shortname
!SBML:reaction:id SBML element ID string SBML Reaction ID
!SumFormula SumFormula formula string Reaction sum formula
!Location shortname string Compartment for localised reaction
!Enzyme shortname string Enzyme catalysing the reaction
!Model text string Model(s) in which reaction is involved
!Pathway text string Pathway(s) in which reaction is involved
!SubreactionOf shortname string Mark as subreaction of a (lumped) reaction
!IsComplete Boolean Boolean Reaction formula includes all cofactors etc.
!IsReversible Boolean Boolean Reaction should be treated as irreversible
!IsInEquilibrium Boolean Boolean Reaction approximately in equilibrium
!IsExchangeReaction Boolean Boolean Some reactants are left out
!Flux number float Metabolic flux through the reaction
!IsNonEnzymatic Boolean Boolean Non-catalysed reaction
!KineticLaw:Name name string Rate law (name as in SBO)
!KineticLaw:Identifiers.obo.sbo shortname string Rate law SBO identifier
!Gene shortname string see table type Enzyme
!Gene:Symbol string string see table type Enzyme
!Operon shortname string see table type Gene
!Enzyme:Name string string Name of enzyme
!Enzyme:Identifiers:ec-code string string EC number of enzyme
!Enzyme:SBML:species:id SBML element ID string SBML ID of enzyme
!Enzyme:SBML:parameter:id SBML element ID string SBML ID of enzyme
!Enzyme:SBML:reaction:parameter:id SBML element ID string SBML ID of enzyme
!BuildReaction Boolean Boolean Includereaction in SBML model
!BuildEnzyme Boolean Boolean Include enzyme in SBML model
!BuildEnzymeProduction Boolean Boolean Describe enzyme production in SBML model
Table 11: Columns that can appear in Reaction tables. The lower section lists, again, column types from
Table B.2.
Relation
Name Type Format Content
!Relation shortname string Type of quantitative relationship
!From shortname string Element at beginning of arrow
!To shortname string Element at arrowhead
!IsSymmetric Boolean Boolean Flag indicating non-symmetric relationships
!Value:QuantityType number float Numerical value assigned to the relationship
Table 12: Columns that can appear in Relation tables.
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Quantity
Name Type Format Content
!Quantity shortname string Quantity / SBML parameter ID
!QuantityType shortname string Quantity type (e.g. from SBO)
ValueType ValueType string Mathematical Term from table 15
!SBML:parameter:id SBML element ID string Parameter ID in SBML file
!SBML:reaction:parameter:id SBML element ID string Parameter ID in SBML file
!Unit text string Physical unit
!Scale text string Scale (e.g. logarithm, see Table 15)
!Provenance text string Name of data source (free text)
!Condition text string experimental condition name (free text)
!pH number float pH value in measurement
!Temperature number float Temperature in measurement
!Location shortname string Compartment (shortname)
!Location:Name string string Compartment (name)
!Location:SBML:compartment:id SBML element ID string SBML ID of compartment‘
!Compound shortname string Related compound (shortname)
!Compound:Name string string Related compound (name)
!Compound:Identifiers:DataCollection resource ID string Compound ID
!Compound:SBML:species:id SBML element ID string SBML ID of compound
!Reaction shortname string Related reaction (shortname)
!Reaction:Name string string Related reaction (name)
!Reaction:Identifiers:DataCollection resource ID string Reaction ID
!Reaction:SBML:reaction:id SBML element ID string SBML ID of reaction
!Enzyme shortname string Related enzyme (shortname)
!Enzyme:Name string string Related enzyme (name)
!Enzyme:Identifiers:DataCollection resource ID string Enzyme ID
!Enzyme:SBML:species:id SBML element ID string SBML ID of enzyme
!Enzyme:SBML:parameter:id SBML element ID string SBML ID of enzyme
!Enzyme:SBML:reaction:parameter:id SBML element ID string SBML ID of enzyme
!Protein shortname string Related enzyme (shortname)
!Protein:Name string string Related enzyme (name)
!Protein:Identifiers:DataCollection resource ID string Protein ID
!Protein:SBML:species:id SBML element ID string SBML ID of enzyme
!Protein:SBML:parameter:id SBML element ID string SBML ID of enzyme
!Protein:SBML:reaction:parameter:id SBML element ID string SBML ID of enzyme
!Gene shortname string Related gene
!Organism shortname string Related organism
Table 13: Columns for numerical values and experimental conditions in tables of type Quantity.
Definition
Name Type Content
!Component component name Name of component (table, column, attribute to be defined)
!ComponentType Table, Column, Attribute Type of component
!IsPartOf component name name of parent component
!Format String Format
!Description Text Free text description of component
Table 14: Columns that can appear in Definition tables.
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C Predefined terms and recommended controlled vocabularies
ValueType Type Format Meaning
Value number float Simple value
Mean number float Algebraic mean
Std number float (positive) Standard deviation
Min number float Lower bound
Max number float Upper bound
Median number float Median
GeometricMean number float Geometric mean
Sign sign {+,-,0} Sign
ProbDist Free text string Prob. distribution
Scale Meaning
Lin Linear scale (no transformation)
Ln Natural logarithm
Log2 Dual logarithm
Log10 Decadic logarithm
Table 15: Terms for mathematical quantities and mathematical scales recommended for use in SBtab.
Names of probability distributions can be, for instance, Normal, Uniform, LogNormal.
Database MIRIAM URN Contents URI
SBO obo.sbo Quantities, rate laws www.ebi.ac.uk/sbo/
CheBI obo.chebi Metabolites www.ebi.ac.uk/chebi/
Enzyme nomenclature ec-code Enzymes www.ebi.ac.uk/IntEnz/
KEGG Compound kegg.compound Compounds www.genome.jp/KEGG/
KEGG Reaction kegg.reaction Reactions www.genome.jp/KEGG/
KEGG Orthology kegg.orthology Genes www.genome.jp/KEGG/
UniProt uniprot Proteins www.uniprot.org/
SGD sgd Yeast gene loci www.yeastgenome.org/
Gene Ontology obo.go Compartments www.geneontology.org/
Taxonomy taxonomy Organisms www.ncbi.nlm.nih.gov/Taxonomy/
SGD sgd Yeast proteins www.yeastgenome.org/
Table 16: A selection of databases to be used in SBtab. For the complete list, see the MIRIAM resources
[2].
Physical entity types
protein complex SBO:0000297
messenger RNA SBO:0000278
ribonucleic acid SBO:0000250
deoxyribonucleic acid SBO:0000251
polypeptide chain SBO:0000252
polysaccharide SBO:0000249
metabolite SBO:0000299
macromolecular complex SBO:0000296
Compartments
cell GO:0005623
extracellular space GO:0005615
membrane GO:0001602
cytosol GO:0005829
nucleus GO:0005634
mitochondrion GO:0005739
Table 17: Examples of biochemical entity types (with Systems Biology Ontology identifiers [4]) and cell
compartments (with Gene Ontology identifiers [7]).
D A note on MIRIAM-compliant models
The MIRIAM rules for computational models [8] have been established to guarantee that published models
contain complete and unambiguous information, and that results from the models can be verified. Note
that MIRIAM-compliance also involves criteria that cannot be ensured by the file structure alone, but are
related to how the model was made, and to the existence of a reference publication (which may or may
not exist for a given SBtab file). (i) The encoded model structure must reflect the biological processes
described by the reference description. (ii) The model must be instantiable in a simulation: all quantitative
attributes must be defined, including initial conditions. (iii) When instantiated, the model must be able to
reproduce all results given in the reference description within an epsilon (algorithms, round-up errors).
However, to allow users to satisfy some of the MIRIAM requirements, SBtab contains document attributes
for information that is mandatory for MIRIAM-compliance. These must be given in the declaration line
of the SBtab document in question, or in the declaration lines of at least one tables belonging to the
document (i) ReferenceDescription (ii) DocumentName (iii) ReferenceCitation (complete citation, unique
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Name SBO term Default unit Entities
standard Gibbs energy of formation SBO:0000582 kJ/mol Compound
standard Gibbs energy of reaction SBO:0000583 kJ/mol Compound
equilibrium constant SBO:0000281 variable Reaction
forward maximal velocity SBO:0000324 mMol/s Enzymatic reaction
reverse maximal velocity SBO:0000325 mMol/s Enzymatic reaction
substrate catalytic rate constant SBO:0000321 1/s Enzymatic reaction
product catalytic rate constant SBO:0000320 1/s Enzymatic reaction
Michaelis constant SBO:0000027 mM Enzyme, Compound
inhibitory constant SBO:0000261 mM Enzyme, Compound
activition constant SBO:0000363 mM Enzyme, Compound
Hill constant SBO:0000190 dimensionless Compound, Reaction
concentration SBO:0000196 mM Compound
biochemical potential SBO:0000303 kJ/mol Compound
standard biochemical potential SBO:0000463 kJ/mol Compound
rate of reaction (amount) SBO:0000615 M/s Reaction
rate of reaction (concentration) SBO:0000614 mM/s Reaction
Gibbs free energy of reaction SBO:0000617 kJ/mol Reaction
standard Gibbs free energy of formation SBO:0000582 kJ/mol Compound
standard Gibbs free energy of reaction SBO:0000583 kJ/mol Compound
transformed standard Gibbs free energy of reaction SBO:0000620 kJ/mol Reaction
transformed standard Gibbs free energy of formation SBO:0000621 kJ/mol Compound
transformed Gibbs free energy of reaction SBO:0000622 kJ/mol Reaction
thermodynamic temperature SBO:0000147 K Location (optional)
ionic strength SBO:0000623 mM Location (optional)
pH SBO:0000304 dimensionless Location (optional)
Table 18: A selection of quantity types to be used in SBtab in table types Quantity. The unit of
equilibrium constants depends on the reaction stoichiometry. More quantities can be found in the Systems
Biology Ontology [4].
identifier, unambiguous URL). The citation should identify the authors of the model. (iv) ModelCreators
(name and contact information for model creators) (v) ModelCreationTime (The date and time of model
creation and last modification) (vi) TermsOfDistribution (link to a precise statement about the terms of
it’s distribution).
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